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Abstract 
An arrhythmia, or cardiac rhythm disorder, is characterized by a change in the normal 
pattern of electrical impulses that occur in the heart.  Cardiac arrhythmias can be life-
threatening.  Adolescents and young adults who have arrhythmias experience challenges 
of youth coupled with the medical challenges associated with their diagnoses.   
Cardiologists who treat these patients are faced with an ongoing need for decision- 
making surrounding addressing alcohol and substance use, which can be prevalent in 
adolescent and young adult populations.  This qualitative study explored what guides 
physicians’ decision-making, as well as physicians’ beliefs and practices regarding how 
they address alcohol and substance use in their cardiac rhythm disorder patients. 
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Chapter 1: Introduction 
Statement of the Problem 
Cardiac rhythm disorders, also known as arrhythmias, are characterized by a 
change in the heart’s normal pattern of electrical impulses (McPherson & Rosenfeld, 
1992).  Heart rhythm disorders are relatively common and many diagnosed with these 
disorders live with disturbances in their daily lives and the constant threat of fatality.  
There are potential accompanying consequences of living with a diagnosis of arrhythmia, 
ranging from implementing necessary behavioral changes to experiencing involuntary 
psychological distress (Priori et al., 2014).  In order to diagnose an arrhythmia, an 
electrocardiogram (ECG) is typically used.  An ECG is a tool used to monitor and record 
the electrical signals of the heart as blood pumps through it (McPherson & Rosenfeld, 
1992).  Many people will occasionally experience an extra heartbeat or two throughout 
their lives and are generally unaffected; however, an unknown, untreated arrhythmia may 
lead to sudden cardiac arrest (McPherson & Rosenfeld, 1992).  
Long QT syndrome (LQTS), a hereditary or drug-induced arrhythmia, is 
characterized by a prolonged QT interval on an ECG (Go et al., 2013).  Patients 
diagnosed with LQTS are susceptible to sudden cardiac death, with a diagnosis 
prevalence of roughly 1 in 2,500 for individuals of European and other ancestries.  When 
untreated, 6% to 13% of those individuals will sustain cardiac arrest or sudden cardiac 
death (Andersen, Øyen, Bjorvatn, & Gjengedal, 2008; Kaltman, Evans, & Fu, 2018).  
There are currently 15 defined subtypes, but the majority of genetically-confirmed cases 
are associated with mutations in three genes, KCNQ1, KCNH2, and SCN5A (Kaltman et 
al., 2018).  Other varieties of arrhythmia have been identified and are in the same
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category as LQTS, including short QT syndrome, supraventricular tachycardia, 
hypertrophic cardiomyopathy (HCM), atrial fibrillation, and Brugada syndrome (Go et 
al., 2013).  
Although these disorders generally present with varying ages of onset and can 
have differing symptoms, each poses the risk of sudden cardiac arrest and sudden cardiac 
death (Go et al., 2013).  Moreover, this risk is made greater when heart rhythm disorder 
patients engage in certain behaviors or experience various emotions (McPherson & 
Rosenfeld, 1992).  These behaviors include but are not limited to sleeping or resting, 
engaging in strenuous or competitive exercise, and ingesting substances that can impact 
one’s heart rhythm (Barsheshet, Dotsenko, & Goldenberg, 2014).  Due to the potential 
impact of these behaviors on a patient’s cardiac rhythm, it is imperative that they are 
addressed by physicians when interacting with patients of all ages.  
Research has shown consistently that, across cultures, the developmental stage of 
adolescence is a period in which risky or reckless behaviors take place (Arnett, 1992).  
The same elevated level of high-risk behaviors exists in young adults (McCabe, Knight, 
Teter, & Wechsler, 2005).  One of the more common reckless behaviors exhibited is the 
use of alcohol and/or other substances (Arnett, 1992).  For the purposes of the current 
study, the definition of “substances” will include illicit drugs, prescribed medications, 
caffeine, and nicotine.  Much of the theory discussed will involve vulnerability to 
engaging in reckless behaviors that could include illegal substance use; however, in the 
operational definition of “substances,” there will also be mention of legal substances, 
including caffeine, nicotine, and drugs prescribed for various medical purposes.  This is 
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because all of the aforementioned substances can impact heart rhythm and, accordingly, 
are equally as important in a discussion between a patient and his or her physician.  
Drinking alcohol to excess and using other substances have been associated with 
cardiac arrhythmia (O’Keefe, Bhatti, Bajwa, DiNicolantonio, & Lavie, 2014).  
Substances associated with sudden death from cardiac dysfunction include anabolic 
steroids, amphetamines, methamphetamine, cocaine, and propylhexedrine (Adgey, 
Johnston, & McMechan, 1995).  Commonly prescribed medications for ADHD, such as 
Ritalin and Adderall, are categorized as stimulants due to the activation of the 
sympathetic nervous system associated with their use (Rohatgi, Bos, & Ackerman, 2015).  
Although stimulants are legal if they are prescribed and used appropriately, they are often 
used for nonmedical purposes, particularly in college-age young adults in the United 
States (McCabe et al., 2005). 
Cardiologists treating adolescent and young adult patients with heart rhythm 
disorders must be more cognizant of alcohol and substance use.  Research has shown 
unfailingly that alcohol and substance use pose a greater risk in young people who have 
the disorders (O’Keefe et al., 2014).  There is an array of research that has contributed to 
literature on alcohol and substance use, within the general population and within the 
cardiac population.  Many studies have been organized to illustrate the effects of alcohol 
and other substances on the heart in a general sense, with both short- and long-term 
findings.  Nevertheless, there is less research available regarding the use of alcohol and 
substances by individuals with heart rhythm disorders.  Adolescents and young adults 
with heart rhythm disorders constitute a specific subset of cardiac patients and are at 
greater risk of having cardiac events based on their propensity to engage in riskier 
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behaviors.  Thus, this subset of patients would benefit from closer attention from their 
doctors.  
The average 4-year medical school dedicates only 12 total hours of curricular time 
to alcohol and drug-related disorders (Miller, Sheppard, Colenda, & Magen, 2001).  
Additionally, physicians generally have negative views about these disorders and do not 
regularly evaluate their patients for them in general practice (Miller et al., 2001).  
Largely, physicians feel incompetent in treating the disorders and do not find treating 
them gratifying (Miller et al., 2001).  Despite potentially negative physician attitudes, 
there are accessible tools used to screen for and evaluate alcohol and substance use in 
medical patients, as well as treatment options for patients experiencing psychological 
difficulty associated with abuse (Barbosa, Cowell, Bray, & Aldridge, 2015).  Moreover, 
although research exists that focuses on the effects of alcohol and substance use in a 
general sense within the cardiac population, there are some gaps that could use more 
consideration.  Namely, how the effects are addressed by cardiologists with patients in 
the adolescent and young adult developmental phases. 
The current study addressed the gap in the literature regarding how cardiologists 
approach alcohol and substance use by adolescents and young adults with heart rhythm 
disorders.  Given this population, it was considered advantageous to examine several 
factors, including the context of a possible discussion, the frequency with which 
physicians engage in this type of discussion, whether the patient’s parent is present when 
a discussion takes place, the specific recommendations for use made by the cardiologists, 
and the perception of cardiologists about who is generally responsible for addressing 
these issues.  This study aimed to collect more information about the aforementioned 
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aspects of patient care.  It also aimed to increase awareness about heart rhythm disorders 
and how affected patients and their families should be educated about the disorder.  This 
could, in turn, support medical professionals in their approach toward young patients with 
cardiac rhythm disorders.  Ultimately, more information on this topic may further 
improve the treatment of these individuals, both from medical and psychological 
standpoints. 
Purpose of the Study 
The purpose of this study was to examine how cardiologists address alcohol and 
substance use by patients ages 13 to 24 with heart rhythm disorders, including LQTS, and 
what the content of those discussions may be.  The study examined how often and under 
what circumstances cardiologists address these issues with patients and examined their 
perceptions of responsibility, importance, and risk for this population of patients.  The 
study also examined the resources used by physicians in order to assist in how they 
address these issues, and their practices within the scope of integrated healthcare.  
Research Question 
What are the beliefs and practices of cardiologists regarding adolescent and young 
adult alcohol and substance use assessment, psychosocial education, and intervention?  
What resources do they use and what are their practices in integrative/collaborative care? 
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Chapter 2: Literature Review 
Heart Rhythm Disorders 
According to the American Heart Association, 7.2% of Americans suffer from 
some type of cardiovascular disease, including 3.2% with coronary heart disease, 2.7% 
with stroke, and 2.0% with congestive heart failure (Go et al., 2013).  A specific subset of 
cardiovascular problems is characterized by malfunctions of the heart rhythm, known as 
arrhythmias (McPherson & Rosenfeld, 1992).  Arrhythmias are defined as any type of 
abnormal heart rhythm and can be separated into two categories: excessively slow heart 
rates (bradycardias) and excessively fast heart rates (tachycardias; McPherson & 
Rosenfeld, 1992).  The underlying problem with an arrhythmia is the result of a 
dysfunction within the heart’s electrical system, which is responsible for pumping blood 
throughout the entire body (McPherson & Rosenfeld, 1992).  The electrical functioning 
of the heart is dependent upon an individual brain’s ability to receive signals, including 
hormonal and reflex signals (McPherson & Rosenfeld, 1992).  Many factors can lead to a 
disturbance of these signals, including physical exertion, emotional arousal, and even 
events occurring in everyday life (McPherson & Rosenfeld, 1992).  
In the United States and Europe, approximately 40% of deaths have been reported 
to be due to life-threatening arrhythmias (Suyama-Chishaki et al., 2007).  
Disconcertingly, when an individual is revived successfully from a life-threatening 
arrhythmic episode, he or she is at 50% risk for having another episode within five years 
(Suyama-Chishaki et al., 2007).  Abnormal heart rates or rhythms are caused by a variety 
of factors and have variable consequences.  The severity of a person’s symptoms alone 
does not necessarily indicate the seriousness of an underlying disorder he or she may 
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have (McPherson & Rosenfeld, 1992).  Symptoms of heart arrhythmias can include 
dizziness, syncope (fainting), chest pain, and shortness of breath (McPherson & 
Rosenfeld, 1992).  Individuals may experience palpitations as missed beats, or single or 
multiple beats, which are reported to be felt anywhere from the stomach to the head 
(McPherson & Rosenfeld, 1992).   
Long QT Syndrome  
LQTS is a disorder that prolongs the QT interval on an ECG, and can be either 
inherited or acquired (Moss, 2003).  The QT interval, a time interval represented on the 
ECG, illustrates the time from the electrical impulse (depolarization) of the heart’s 
working chambers (ventricles) to the end of the recharging of the electrical system of the 
heart (repolarization; Schwartz et al., 2009).  The QT interval is measured in 
milliseconds; it closely approximates the time from the onset of the ventricles’ 
contraction until the end of relaxation (Schwartz et al., 2009).  A prolonged QT interval is 
associated with an increased risk of syncope and can lead to sudden cardiac death caused 
by ventricular fibrillation (Barsheshet et al., 2014).  Despite the fact that patients with 
very prolonged repolarization times appear to be at a higher risk for having cardiac 
events, sudden cardiac death can occur in those who present with normal repolarization 
as well (Knoche, Orland, January, & Maginot, 2012).  
LQTS was first identified in 1957, when several children in a family experienced 
QT prolongation on ECGs and recurring episodes of fainting and sudden death (Moss, 
2003).  In the 1990s, after familial patterns were explored via research, the genetic basis 
of LQTS was discovered; there are currently identified mutations in 15 LQTS genes 
(Chaix et al., 2016; Kaltman et al., 2018; Moss, 2003).  LQTS is considered an 
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infrequently occurring disorder in the general public.  The prevalence of LQTS has been 
estimated to be 1 in 2,500, but this number could be considered a low estimate because, 
in up to 37% of cases where LQTS is genetically inherited, the disorder is concealed or 
negligible on an ECG (Barsheshet et al., 2014).  An interesting aspect of LQTS is the 
variability in symptom expression; the significant variability suggests that other genetic 
factors, as well as environmental factors, can be influential components in diagnosis 
(Moss, 2003). 
Individuals affected by LQTS may present with fainting spells, sudden cardiac 
death, or prolongation of the QT interval on an ECG during a regular check-up or exam 
(Moss, 2003).  Following an episode of syncope, if an individual has an identified QT 
prolongation on his or her ECG, the diagnosis of LQTS is positive (Moss, 2003).  For 
these individuals, it is vital to obtain ECG readouts on all first-degree family members to 
determine whether others are affected (Moss, 2003).  It is important to note in the 
discussion of LQTS that several types of drugs can prolong the QT interval; however, 
there is a distinct difference between drug-induced QT prolongation and the genetically-
inherited form of the disorder (Moss, 2003). 
Types of LQTS.  Currently, there are 15 identified genes associated with 
inherited LQTS, with most being caused by changes in potassium or sodium ion channel 
functioning (Chaix et al. 2016; Kaltman et al., 2018; Knoche et al., 2012).  The most 
common types of LQTS, accounting for over 95% of gene-specific LQTS and 75% of all 
patients with LQTS, are LQT1, LQT2, and LQT3 (Barsheshet et al., 2014).  An important 
aspect of distinguishing between the three main types of LQTS is that each has distinctive 
primary triggers for cardiac events.  For example, in LQT1, patients primarily experience 
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events during exercise, whereas LQT2 patients primarily experience events resulting 
from acute emotional arousal and LQT3 patients primarily experience events during sleep 
or while at rest (Moss, 2003).  
 The course of the disorder presents differently across patients with LQTS and is 
impacted by genotype, gender, environmental factors, and types of treatment applied 
(Moss, 2003).  For example, the risk of having a cardiac event is significantly higher 
among patients with LQT1 and LQT2 mutations than in those with LQT3 (Barsheshet et 
al., 2014).  Additionally, LQT1 patients typically present with the youngest age at the 
time of first clinical onset of the disorder; however, events for persons with LQTS3 are 
more likely to be fatal (Moss, 2003).  In a general sense, across all types of LQTS, 
sudden death can occur within any age group, but these occurrences have an increased 
frequency in adolescence (Moss, 2003).  
Diagnosis.  LQTS can be diagnosed from results of an ECG, genetic testing, 
and/or clinical interviews including family history (Barsheshet et al., 2014).  At the most 
fundamental level, the ECG is used to detect the heart’s patterns of electrical currents; 
they are most effective for accurately diagnosing if the patient is experiencing symptoms 
at the time of the ECG (McPherson & Rosenfeld, 1992).  Nevertheless, this may not 
always be an option, as in many cases the symptoms present briefly and are inconsistent 
in frequency (McPherson & Rosenfeld, 1992).  An option used in some cases includes 
having the patient perform an exercise test while wearing ECG equipment, as physical 
activity can provoke an arrhythmia (McPherson & Rosenfeld, 1992).  An additional 
option utilized in medical settings is a transesophageal ECG, which consists of ECG 
electrodes being swallowed by the patient or inserted via the patient’s mouth (McPherson 
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& Rosenfeld, 1992).  This particular technique is useful in cases that may be difficult to 
diagnose, as the esophagus is located directly behind the atria in the heart (McPherson & 
Rosenfeld, 1992).   
Difficulty in diagnosing LQTS is due to genetic mutations having what 
researchers call “variable expressivity,” meaning that a prolonged QT interval on an ECG 
may not always be present in an affected patient (Behere, Shubkin, & Weindling, 2014).  
Therefore, there is a specific set of diagnostic criteria that typically include one or more 
of the following: (a) if a prolonged QT interval on an ECG is detected after an event of 
syncope when the individual does not have an acquired case, (b) if there is a very 
prolonged QT interval in repeated ECGs that is not caused by a secondary factor for the 
prolongation, and (c) if there is an LQTS risk score, based on family history, personal 
history, symptoms, and ECG, of more than or equal to 3.5 and/or there is a concrete 
presence of an LQTS gene (Barsheshet et al., 2014). 
Diagnostic criteria also include the individual’s history, taking into consideration 
gender and age for clinical purposes (Barsheshet et al., 2014).  LQT1 patients present 
with the youngest age with the first clinical manifestation of the disease, with 86% 
showing symptoms before the age of 20 (Barsheshet et al., 2014).  Syncope and sudden 
cardiac death can occur at any age in LQTS patients; however, the overall risk for these 
events is higher in adolescents (Moss, 2003).   
Treatment.  Despite the fact that electrophysiology has allowed for advancement 
in the treatment of heart rhythm disorders, the type of treatment a patient receives is 
decided ultimately by a range of factors, including the patient’s overall physical health, 
lifestyle, and tolerance of the accompanying symptoms (McPherson & Rosenfeld, 1992).  
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Generally, LQTS treatment includes lifestyle modification, pharmacological therapy, and 
device and surgical therapy (Barsheshet et al., 2014).  The treatment of a LQTS patient, 
however, is established based on individual differences.  
In terms of medication, LQTS is treated with beta-blockers as a first-line 
intervention; additional pharmacological treatment options include sodium channel 
blockers and calcium channel blockers (Behere et al., 2014).  Beta-blocking drugs are 
given to patients with both asymptomatic and symptomatic LQTS (Behere et al., 2014).  
Interestingly, beta-blocking drugs have little impact on the length of the QT interval and 
are mostly effective in decreasing the frequency of syncope events (Moss, 2003).  When 
discussing medications for the treatment of LQTS, it is important to note that mexiletine 
is effective in shortening the QT interval; however, it has proven to be most effective for 
LQT3 (Sicouri, Antzelevitch, Heilmann, & Antzelevitch, 1997).  
Within a discussion of pharmacological treatments for LQTS, it is important to 
note that the use of beta-blockers in conjunction with certain illicit substances, 
particularly opiates and amphetamines, can be dangerous (Krishnamoorthy, Lip, & Lane, 
2009).  Beta-blockers can also cause negative side effects including mood swings, 
depression, and fatigue that may result in noncompliance, particularly in adolescents 
(Farnsworth, Fosyth, Haglund, & Ackerman, 2006). 
Patients who still present with symptoms despite being treated with appropriate 
doses of beta-blockers are typically treated in the United States by implantable cardiac 
defibrillator devices (ICDs; Behere et al., 2014).  These devices monitor the individual’s 
heart rhythm and can provide a shock if a potentially life-threatening arrhythmia is 
detected (Behere et al., 2014). 
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Because different mutations of the LQTS gene can be characterized by different 
environmental triggers, there is some understanding on the part of medical professionals 
about how to take preventative measures to protect the patient.  For example, patients 
with LQT1 who experiences most of their cardiac events while engaging in strenuous 
physical activities should avoid those activities unless they have adequate supervision or, 
depending on their risk level, avoid them altogether (Barsheshet et al., 2014).  Further, 
patients with LQT2, who experience cardiac events as the result of intense emotional 
arousal, should be encouraged to avoid loud noises, including alarm clocks, fireworks, 
doorbells, and ringing telephones, and patients with LQT3, who experience events during 
sleep or at rest, may be encouraged to not sleep alone (Barsheshet et al., 2014).  
Across all types of LQTS, however, there is one uniform recommendation: all 
patients should avoid substances that are known to prolong the QT interval, decrease 
potassium levels, decrease magnesium levels, or contribute to any kind of electrolyte 
imbalance (Barsheshet et al., 2014).  Moreover, for all LQTS patients, but perhaps more 
importantly for younger patients who may get sick more frequently, it is important to 
address any electrolyte imbalances that could occur from diarrhea or vomiting.  Of 
course, an individual with a diagnosis of LQTS should avoid these drugs and remain 
cognizant of drug effects, but someone without a diagnosis may also ingest these types of 
drugs and acquire the disorder.  Some drugs that can prolong the QT interval include 
types of gastrointestinal prokinetics, antiemetics, antibacterials, general anesthesia agents, 
opioids, antimigraine agents, antipsychotics, antiasthmatics, antihistamines, and 
antidepressants (De Ponti et al., 2002).  
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Within a discussion of pharmacological treatments for LQTS, it is important to 
note that the use of beta-blockers in conjunction with illicit substances, particularly 
opiates and amphetamines, can be extremely dangerous (Krishnamoorthy et al., 2009).  
Unfortunately, research on non-antiarrhythmic drugs that can cause prolongation of the 
QT interval has caused a level of perplexity for clinicians; one factor contributing to this 
confusion is the sometimes questionable clinical evidence for certain drugs (Ponti et al., 
2002).  Nevertheless, there has been a steady effort over the past several years to create a 
more comprehensive list of these drugs that are backed by strong clinical evidence (De 
Ponti et al., 2002). 
In addition to the research conducted on the impact of non-antiarrhythmic drugs 
on LQTS, there also have been a number of studies conducted highlighting the 
epidemiological and clinical impact of the disorder (Andersen et al., 2008).  Much of this 
research has focused on factors such as gender and age. 
Gender.  According to the research, there are some gender differences across age 
groups in patients with LQTS.  In one study of individuals with LQT1, results showed 
that in an age range between 0 and 13 years, there was a two-fold increased risk for 
sudden cardiac death in males compared to females, whereas with LQT2, the risk for life-
threatening cardiac events during the same age range was similar between males and 
females (Barsheshet et al., 2014).  There are interesting differences between the risk of 
cardiac events for males and females and these differences occur within the childhood to 
adolescence phase of development (Go et al., 2013).  For example, the risk of having a 
cardiac event is higher in boys than girls before the age of 12.  Conversely, the risk of 
having a cardiac event during young adulthood is higher among females than males (Go 
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et al., 2013).  The literature has shown, however, that for all three types of LQTS, the 
likelihood of experiencing a cardiac event increases significantly during adolescence 
(Moss, 2003). 
Other Arrhythmias  
Other types of arrhythmias have been identified and have both similarities with 
and differences from LQTS (Hamang et al., 2010).  For example, both LQTS and HCM 
have a genetically-based risk for potentially life-threatening arrhythmias and sudden 
death that could apply to children, teenagers, and adults (Hamang et al., 2010).  
Nevertheless, the nature of these disorders can be different, which can lead to differences 
in quality of life, beliefs about health status, and psychological well-being (Hamang et 
al., 2010).  Interestingly, HCM presents with symptoms that are more likely to impact 
daily physical health, whereas LQTS may be more likely to cause worry and distress due 
to the uncertain nature of the symptoms, diagnosis, and treatment of the disorder 
(Hamang et al., 2010). 
Adolescence 
Throughout human development, diverse characteristics are acquired within the 
scope of an individual’s ever-changing personality; brain functions begin to advance, the 
person gains valuable, lifelong skills, and influential interpersonal relationships are 
formed.  According to relational developmental systems theory, human development is 
considered susceptible to change, and healthy development is the direct result of mutually 
advantageous interactions between an individual and his or her environment that unfold 
over time (Wray-Lake, Syversten, & Flanagan, 2016).  Positive interactions between an 
individual and his or her environment, however, are only one piece of the developmental 
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puzzle.  There are other components contributing to developmental growth, which 
typically adjust over time, including social responsibility, executive functioning, and 
decision-making (Friedman et al., 2016; Wray-Lake et al., 2016).  
According to the literature, adolescence is defined as a transitional time period 
“marked by the onset of puberty and extending through the late teens into the early 20s” 
(Luna & Wright, 2016, p. 91.  Adolescence is a unique time of both transformation and 
challenges, particularly because adolescents are considered largely to be immature when 
compared to adults in various respects (Nagel, Guarnera, & Reppucci, 2016).  
Biologically, cognitively, socially, and emotionally, adolescents are underdeveloped 
when compared to fully matured adults (Nagel et al., 2016).  Adolescence is a 
particularly crucial time in an individual’s life; it is a developmental period during which 
an individual begins to establish autonomy from his or her parents, creates close 
interpersonal bonds, and experiences various major changes within his or her biological 
state (Ehrlich, Hoyt, Sumner, McDade, & Adam, 2015).  
Many of the fundamental changes which occur during the timeframe of 
adolescence are considered beneficial; however, there are also several risk factors to 
which adolescent individuals are exposed.  Studies have shown that between the ages of 
13 and 18, individuals are in a critical period for the onset of depression (Hankin et al., 
2015).  Additionally, the literature shows that low quality relationships between the 
adolescent and his or her parents, as well as between the adolescent and his or her peers, 
are linked to an increased risk for developing a range of both internalizing and 
externalizing adjustment disorders (Ehrlich et al., 2015).  
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Adolescent decision-making, recklessness, and risk-taking.  Individuals in the 
teenage and young adult phases of development may make decisions differently from 
those in other developmental phases.  The adolescent brain includes underdeveloped 
areas, such as the basal ganglia and prefrontal cortex, which can contribute to risk-taking 
behavior (Luna & Wright, 2016).  Evidence shows that various specific behaviors exist 
within adolescence, and some of those behaviors can vary across different geographical 
locations and time periods (Arnett, 1992).  Society in general, and parents in particular, 
tend to view adolescence as a time of major behavioral changes, some of which can be 
characterized by defiant behavior or emotional outbursts (Luna & Wright, 2016).  One 
specific trait that has been linked to adolescence much more strongly than any other 
developmental stage regardless of culture or time period is reckless behavior (Arnett, 
1992).  Although the reasons behind some of the difficulties adolescents experience vary 
in the research, it is a stable conclusion that adolescents are more likely to engage in 
risky, reckless behaviors (Arnett, 1992).  The exact nature of how these behaviors are 
carried out, however, is less clear (Arnett, 1992).  
The ways in which adolescent recklessness is expressed depend upon the dynamic 
of the culture in which the adolescent is living, as well as the particular time period 
(Arnett, 1992).  For example, in the early 19th century, before the invention of the 
automobile, reckless driving would not have been a problem because driving was not yet 
part of society, but in today’s society, reckless driving certainly presents a potential 
hazard (Arnett, 1992).  When discussing the topic of driving recklessly, Arnett (1992) 
also points out that adolescents are not only more likely than individuals in other 
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developmental phases to drive after consuming alcohol, but they are more likely to drive 
faster, closer to other vehicles on the road, and fail to use seatbelts.   
Some researchers argue with the concept of recklessness itself, suggesting that the 
notion should be defined subjectively rather than categorizing general behavior as such 
(Jessor, 1991).  For example, Jessor (1991) identified the failure to use contraception as a 
stigmatized “reckless behavior;” however, he asked the following questions: What if the 
woman in question either did not have access to it, or was not concerned whatsoever 
about the consequences of not using it?  Does that inherently make the behavior of not 
using contraceptive reckless?  Jessor theorized that each behavior should be evaluated as 
reckless on a case-by-case basis.  Similarly, Arnett (1992) attempted to distinguish the 
difference between danger and risk-taking, stating that danger is typically recognized but 
purposely minimized, whereas risk-taking occurs when certain precautions could be 
taken but purposely are not. 
Arnett (1992) identified two factors that appear to be integral to an adolescent’s 
reckless behavior: sensation-seeking and egocentrism.  Arnett posited that these two traits 
emerge in adolescence and decrease gradually throughout adulthood.  He explained that 
sensation-seeking is a component of an individual’s personality that contributes to his or 
her need to experience novel and varied sensations (Arnett, 1992).  Arnett explained that 
this need implies that the individual is willing to take “physical and social risks,” even 
searching eagerly for reckless behaviors in which to engage so her or she can feel these 
varied, complex sensations.  Luna and Wright (2016) explained that sensation-seeking is 
characterized by “the pursuit of thrills, adventure, and experience as well as disinhibition 
and susceptibility to boredom” (p. 91).  
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Research has highlighted the Sensation Seeking Scale, which consists of four 
subscales: Thrill and Adventure Seeking, Disinhibition, Boredom Susceptibility, and 
Experience Seeking (Zuckerman, 1996).  On the Sensation Seeking Scale, scores are 
highest at age 16 and decrease gradually with age (Zuckerman, 1996).  With egocentrism, 
defined by Piagetian theory as a failure to distinguish between where the self ends and 
the other begins, research has shown that by the time an individual reaches adolescence, 
he or she has not overcome this developmental obstacle (Arnett, 1992).  The importance 
behind this lack of overcoming egocentrism lies in the fact that adolescents may think 
others are preoccupied with their behaviors and appearance in the same way that they are 
(Arnett, 1992).  In turn, this belief may lead to the thought that they are actually 
invincible to the penalties of reckless behaviors (Arnett, 1992). 
It is noteworthy that much of the previous research conducted surrounding risk 
behavior in adolescence has shown that taking risks serves an important developmental 
purpose (Jessor, 1991).  According to Jessor (1991), adolescent risk-taking behaviors are 
“functional, purposive, instrumental, and goal-directed” (p. 378), and the goals being 
achieved are quite typical within the scope of adolescent development.  Luna and Wright 
(2016) stated that it is an adaptive process necessary for gaining skills that support 
autonomous trajectories as adults.  Jessor explained that most of the risk-taking behaviors 
considered typical in adolescence are, essentially, functional within this time frame. 
Jessor pointed specifically to these risk-taking behaviors as methods of gaining 
acceptance and respect from peers, establishing independence from parental figures, 
rejecting the norms of authority, managing anxiety, frustration, and potential failure, and 
asserting personal maturity and making a smooth transition out of childhood.  Jessor also 
ADDRESSING DRUG USE WITH YOUNG CARDIAC PATIENTS 19 
 
stated that there is nothing inherently illogical about attempting to meet these goals as an 
adolescent; on the contrary, they are representative of conventional development that help 
to explain why these behaviors may be so difficult to change. 
Interestingly, Steinberg (2007) described the process of risk-taking as a 
competition between the “socioemotional and cognitive-control networks,” stating that, 
while in the presence of peers, an adolescent’s socioemotional network becomes 
activated, leading to a weakened regulatory effect of the cognitive-control network.  
Steinberg also posited that risk-taking may be heightened during adolescence because of 
the large amount of time an adolescent spends with peers.  From a neuroscience 
perspective, the reward centers of the brain are activated more prominently during risky 
situations than they are during situations in which individuals receive non-social rewards 
by themselves (Steinberg, 2007).  The competition described between the socioemotional 
and cognitive-control networks has been examined from a variety of contexts in which 
decision-making is involved, including drug use, social-decision processing, moral 
judgments, and the assessment of alternative rewards and costs (Steinberg, 2007).  Across 
all of these contexts, risk-taking is associated with more prominent activation of the 
socioemotional network; this association is likely due to the fact that immediate rewards 
are particularly emotionally arousing (Steinberg, 2007). 
When discussing risk, it is important to characterize differences between 
biological and behavioral risk.  For example, with general cardiovascular disease, high 
serum cholesterol and hypertension have been identified as biological risks (Jessor, 
1991).  In contrast, behavioral risk includes engaging in behaviors likely to lead to 
negative consequences (Jessor, 1991).  Biological risk can also be associated with 
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behavioral risk (Jessor, 1991).  For example, certain illnesses, including HIV, cancer, and 
liver disease, can be associated with behavioral patterns (Jessor, 1991).  
A notable paradigm exists when examining risk-taking in cardiac rhythm patients 
and the use of alcohol and other substances.  An individual with a genetic predisposition 
to developing a cardiac rhythm disorder is inherently at greater biological risk than an 
individual without the genetic component.  Knowing this information, however, could 
lead to behavioral risk.  A teenager or young adult who is aware of his or her potential to 
be diagnosed with a heart rhythm disorder may feel ostracized or worried, leading him or 
her to engage in unhealthy behaviors to cope with these emotions.  Undoubtedly, the 
knowledge of a genetic predisposition to a heart rhythm disorder does not always lead to 
engaging in risky behavioral patterns, but it is feasible and should be taken into account.  
On the contrary, engaging in such risky behavioral patterns without a genetic 
predisposition to these disorders may actually lead to a greater biological risk of 
developing symptoms of one.  Research has shown conclusively that, whether short- or 
long-term, heavy alcohol use can bring on an arrhythmia and, in rare cases, sudden 
cardiac death (O’Keefe et al., 2014).  In addition, withdrawal from alcohol increases 
cardiac sympathetic activity and heart rate variability, which are both fundamentally 
linked to arrhythmias (O’Keefe et al., 2014).  When discussing risk, it is also important to 
note that some risky behaviors engaged in commonly by adolescents and young adults 
can have major impacts on cardiac status.  For example, risky sexual behaviors, those that 
can lead to sexually-transmitted diseases or pregnancy, are common in adolescence 
(Gupta, 2014).  Some research has shown that adolescents with congenital heart disease 
are less likely to be sexually active at a young age due to psychosocial developmental 
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delay or uncertainties regarding their diagnosis; however, of those 16- to 18-year-olds 
with congenital heart disease who are sexually active, up to 75% are likely to engage in 
risky sexual behavior, including having more than two partners in a 3-month period, 
using drugs or alcohol before having sex, and failing to use contraception (Gupta, 2014).  
A heavily studied topic within research on adolescence is social responsibility, 
which is identified as a fundamental display of psychosocial maturity, an indicator of 
general well-being, and an aftereffect of positive youth development (Wray-Lake et al., 
2016).  Decision-making also plays an integral role in human development.  Making the 
“right” choices is often emphasized throughout all stages of life; however, deciding to 
engage in healthy behaviors is often dependent upon the individual’s goals (Reyna & 
Farley, 2006).  In adolescence, and often in young adulthood, goals are more likely to be 
based on achieving immediate pleasure rather than long-term results (Reyna & Farley, 
2006).  For this reason, it is plausible that certain types of unhealthy behaviors, including 
alcohol and substance use, may seem like the best option for an adolescent (Reyna & 
Farley, 2006).  The emphasis on maximizing immediate pleasure through potentially 
unhealthy behaviors, in addition to a heart rhythm disorder diagnosis, can lead to 
detrimental outcomes.  
Peer pressure.  In the United States, teenagers and adolescents in the general 
population are particularly vulnerable to social pressures.  Peer pressure, in particular, 
occurs for a variety of reasons, including the desire to be associated with a certain group 
of same-aged individuals (Lewis & Lewis, 1984).  Peer pressure often presents itself in 
the form of “dares,” many of which are comprised of using alcohol and illicit substances 
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(Lewis & Lewis, 1984).  Substance use is one example of a “problem behavior” as 
described by Jessor (1991) 
Jessor (1991) focused on identifying and describing the trajectory of what he 
termed “problem behaviors,” which occur during adolescence and are related to 
adolescent risk-taking.  Jessor identified “drug and alcohol use, permissive sexuality, and 
other actions associated with deviance such as aggression, lying, and stealing” (p. 380) as 
part of the greater category of problem behaviors, in addition to any actions which may 
place the individual at personal risk of injury.  Jessor’s theory suggested that problem 
behaviors are the result of three factors: personality, environment, and other behaviors.  
Moreover, he found that these problem behaviors occur more often among individuals 
who place higher value on autonomy, have low expectations for their own academic 
achievement, generally accept deviant behaviors, and have low levels of religiosity 
(Jessor, 1991).  Most importantly, however, was his finding that the environmental 
factors contributing to problem behaviors included “the existence of peers who model 
these behaviors, a low degree of support or control from adult significant others, friends 
exceeding parents as sources of influence, and social pressure from peers who model a 
problem behavior” (Jessor, 1991, p. 342).  
When examining adolescence from an Ericksonian perspective, one may conclude 
that this stage of development is geared mostly toward gaining a sense of identity (Jessor, 
1991).  During this stage of development, parental figures have lost their positions as 
“essential supports” and are replaced, in a sense, by the individual’s peer group (Jessor, 
1991).  Erickson posited that “dares” and role playing, as well as verbal exaggerations of 
dares, are normal components of social play, and Jessor (1991) expanded upon this idea.  
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Jessor believed that role models and the sources of pressure individuals experience act on 
their vulnerability for developing problem behaviors and channel the vulnerability into 
particular actions.  One study conducted with school-age children showed that with 
increasing age and grade level, dares connected to peer pressure occurred with more 
frequency; in fact, they occurred twice as much in junior high school than in elementary 
school (Jessor, 1991).  The content of the dares also changed: Among eighth graders in 
particular, dares began to include challenges to smoke marijuana, vandalize, and commit 
acts of violence toward others (Jessor, 1991).     
Alcohol and Substance Use 
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-5) states that, in order for a person to be diagnosed with a substance use disorder, 
he or she must demonstrate at least 2 of 11 possible symptoms (American Psychiatric 
Association [APA], 2013).  Examples of these symptoms include but are not limited to 
continuing to use past what was originally planned, continuing to use despite 
experiencing adverse consequences, and building a tolerance to the substance (APA, 
2013).  In the United States, individuals can drink legally at age 21.  Before this age, 
drinking alcohol in any capacity could be considered reckless; over the age of 21, driving 
while intoxicated is considered reckless (Arnett, 1992).  This varies significantly across 
cultures.  Some countries have a lower legal drinking age, which brings forth the risk of 
drunk driving at a younger age (Arnett, 1992). 
The misuse of alcohol consists of risky and harmful drinking, alcohol abuse, and 
alcohol dependence (Whitlock, Polen, Green, Orleans, Klein, 2004).  In Americans ages 
12 and older, 23% have reported “unhealthy” use of alcohol on at least one occasion 
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during the past 30 days, 8% reported using illicit drugs (including nonmedical use of 
prescription drugs) within the past 30 days and 2.8% showed evidence for drug abuse or 
dependence (Holt et al., 2013).  One study found that the typical age of a child’s first use 
of alcohol that is described as “more than a few sips” occurs between the ages of 13 and 
15 (Grant, Stinson, & Harford, 2001).  Another study indicated that 40% of adult 
alcoholics reported an onset of alcoholism symptoms between the ages of 15 and 19 
(Reyna & Farley, 2006).  It is important to note that, according to the literature, the 
earlier in life an individual begins drinking, the more likely he or she is to develop 
“problem drinking.”   
Many years ago, the phrase “holiday heart” began being used to describe the 
instances of acute atrial fibrillation (AF) that were seen frequently in those drinking 
heavily during celebratory occasions (O’Keefe et al., 2014).  Research has shown that the 
first time an individual is exposed to alcohol, which is typically in the context of a family 
gathering or religious event, occurs before the age of 15 (Grant et al., 2001).  This 
association between religious or family gatherings and heavy alcohol use is something 
that is entrenched in American culture and can have a negative impact on adolescents, 
who are already prone to more risk-taking and reckless behaviors (Arnett, 1992).  
Substance use is a common problem in the United States and results in 
interpersonal and financial costs.  Although alcohol use is generally socially acceptable in 
many cultures, including American culture, illicit substance use is viewed as much more 
of a public health problem (van Boekel, Brouwers, van Weeghel, & Garretsen, 2013).  
When coupled with alcohol use, illicit drug use constitutes 4% of worldwide causes of 
death and accounts for 5.4% of the global burden of disease (van Boekel et al., 2013).  
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Substance use problems also pose the risk of creating further societal difficulties, 
including accidents, absenteeism at places of employment, and loss of productivity (van 
Boekel et al., 2013).  One 2009 study found that only 14.7% of individuals with 
substance dependence received professional assistance in the previous year (Grella, 
Karno, Warda, Moore, & Niv, 2009).  Furthermore, although it has been shown that 
treatment increases the likelihood of recovery, only 24.1% of those with lifetime alcohol 
dependence ever seek treatment (van Boekel et al., 2013).  
Research has shown that there are several factors involved with individuals 
choosing to receive treatment for these disorders.  First, the utilization of treatment is 
higher among those who have problems with more than one type of substance, as well as 
those with co-occurring mental illness (Grella et al., 2009).  Second, another factor 
associated with the use of services is the individual’s perception of need and willingness 
to seek help.  The populations afflicted most by unmet needs for treatment are the elderly, 
those from racial/ethnic minority groups, those with low incomes, those without 
insurance, and those living in rural areas (Grella et al., 2009).  
Young adults between the ages of 18 and 24 encompass a specific subset of 
individuals who are central in the discussion of risk-taking and reckless behavior: college 
students.  Research has shown that the mere presence of peers increases the likelihood of 
risk-taking. This likelihood is especially high for teenagers, but also moderately high for 
college-age individuals (Steinberg, 2007).  In one study, results showed that the presence 
of peers increased the level of risk-taking in college undergraduates by 50% (Steinberg, 
2007).  College-age individuals are at a particularly high risk for both alcohol and 
substance use.  Studies have shown that the population in the United States most likely to 
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engage in binge drinking is college undergraduates.  Furthermore, many studies have 
been conducted in recent years highlighting a rising trend among college students: the 
nonmedical use of stimulant medications (McCabe et al., 2005). 
Drugs such as methylphenidate, dextroamphetamine, and mixed-salts 
amphetamine are considered pharmacological treatment for attention deficit hyperactivity 
disorder (ADHD; McCabe et al., 2005).  In the United States, not only is the prevalence 
of ADHD diagnoses higher than in other countries, but the use of prescription stimulants 
is also higher (McCabe et al., 2005).  Use of these drugs for legitimate diagnoses of 
ADHD has been shown to be extremely efficacious; however, the increased frequency of 
use of these medications in the United States has caused public health concern for several 
reasons (McCabe et al., 2005).  The main source of concern with the use of these 
medications is the potential for abuse and, disturbingly, college students in particular are 
among the group of individuals using the medications for nonmedical purposes the most 
(McCabe et al., 2005).  Knowing that college-age individuals are more likely to succumb 
to the influence of peers and engage in high-risk behaviors, these data are particularly 
important.  
Caffeine and nicotine.  More than 50% of Americans drink coffee on a daily 
basis, and more consume caffeine in either coffee or another form, such as tea, soda, and 
chocolate (Pelchovitz & Goldberger, 2011).  Generally, research conducted with both 
human and animal subjects regarding the effects of caffeine on the heart’s rhythm has 
been somewhat inconsistent (Klatsky et al., 2011).  Despite this, it has been found 
conclusively that caffeine increases individuals’ resting energy expenditure, sleeping 
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metabolic rate, and resting awake metabolic rate by increasing activity in the sympathetic 
nervous system (Glade, 2010).    
Alcohol and substance use screeners.  Within the scope of medical settings, 
there are members of a particular population that should be paid close attention by 
physicians: cardiac patients.  Patients suffering from cardiovascular problems represent a 
large portion of the American population and, unfortunately, many of those patients 
experience potentially fatal heart arrhythmias (Go et al., 2013).  As the research has 
shown, many types of illicit drugs and medications can impact the heart’s rhythm 
significantly.  This highlights the need for increased awareness surrounding the use of 
both illicit and prescribed or over-the-counter medications and the potential effects they 
can have on an individual’s heart rhythm (Moss, 2003).  
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) encourages 
doctors to identify individuals who are at risk for alcohol problems or currently have 
them; they are also encouraged to provide brief interventions or referrals to outside 
sources if needed (Whitlock et al., 2004).  Studies have yielded variable results when 
looking at the success of screening and brief intervention (SBI) for alcohol and substance 
use (Broderick, Kaplan, Martini, & Caruso, 2015; Haller et al., 2014).  In primary care 
settings, SBI has been indicated to be successful (Barbosa et al., 2015).  Research has 
shown that SBI can decrease weekly alcohol consumption by 13% to 34% (Le et al., 
2015).  There are barriers to implementing SBI, including physicians’ lack of confidence 
in assessing use and providing brief recommendations or feedback (Le et al., 2015).  This 
has been connected to a lack of training and low levels of physician self-efficacy; 
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however, variables impacting physician confidence levels are undetermined (Le et al., 
2015). 
Physicians and Stigma 
One aspect of alcohol and substance use disorders that is distinctly different from 
other types of disorders is the associated shame and stigma.  Many patients will simply 
choose not to disclose to their physicians that they think they have a problem.  Mental 
health stigma consists of four “social-cognitive processes,” including cues, stereotypes, 
prejudice, and discrimination (Bulanda, Bruhn, Byro-Johnson, & Zentmyer, 2014).  Cues 
are described as the way members of the general public identify an individual with 
mental illness, including the individual’s external appearance, any deficits in social skills, 
or psychiatric symptoms (Bulanda et al., 2014).  When examining stigma associated with 
mental illness, common stereotypes could include the idea that the individual suffering is 
weak, incompetent, or even dangerous (Bulanda et al., 2014).  These stereotypes could 
lead to prejudice, the belief that the stereotype is true and that one should make decisions 
based on it, which, in turn, could lead to discriminatory behaviors against the identified 
group (Bulanda et al., 2014).  Discriminatory behaviors can be exhibited in many forms, 
including bullying or social ostracism, both common in adolescent populations (Bulanda 
et al., 2014).  In a 1999 report by the Surgeon General, stigma was identified as the most 
salient obstacle to receiving mental health treatment (Bulanda et al., 2014).  
Stigma is a concept that is acquired early in life, as young people develop 
stigmatizing analyses of their peers, especially peers with mental health issues.  Self-
stigma is something that can be affected by a number of factors, including the self-stigma 
of a child’s parent regarding having a child with a mental health issue (Bulanda et al., 
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2014).  Justifiably, self-stigma has been associated through research with lack of seeking 
treatment, decreased self-esteem and self-efficacy, and decreased quality of life (Luoma 
et al., 2007). A major factor contributing to a substance abusing individual not seeking 
treatment is the fear of stigma, which often leads to avoidance of treatment and failure to 
seek medical help (Luoma et al., 2007).  Furthermore, research has shown that school-age 
children who have either restricted or inaccurate knowledge about mental illness have 
more stigmatizing views toward those afflicted with mental health disorders (Bulanda et 
al., 2014).  
It has been indicated through various studies over the years that stigma is an 
important factor when engaging a patient in alcohol and substance use treatment, and 
there are several types of stigma that require understanding when treating young patients 
in particular (Luoma et al., 2007).  Enacted stigma includes straightforward 
discrimination, including social rejection, difficulty finding a job, or ostracism (Luoma et 
al., 2007).  Perceived stigma, the beliefs an individual within a stigmatized group may 
hold about the prevalence of stigma in society, could be accurate or inaccurate based on 
the individual’s opinions (Luoma et al., 2007).  Lastly, self-stigma is the self-imposed 
negative beliefs an individual holds about his or her inclusion in a stigmatized group; 
these negative views could result in shame, guilt, or fear (Luoma et al., 2007). 
Patients with alcohol and substance use problems are typically considered 
problematic to manage and treat due to their dependence, and they are often labeled as 
“difficult patients” (Lindberg, Vergara, Wild-Wesley, & Gruman, 2006).  Research has 
shown that physicians generally have negative attitudes toward these disorders.  Studies 
have indicated they do not feel confident in treating them and their attitudes toward these 
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disorders become progressively worse as their training continues (Miller et al., 2001).  
Additionally, the literature has also demonstrated that medical doctors and students have 
higher levels of stigmatizing mental illness than do nurses and even the patients 
themselves (Sickel, Seacat, & Nabors, 2014).  One study also found that participants 
reported 40% less willingness to pay for mental illness treatment versus medical illness 
treatment, despite an equal perceived societal burden with both illnesses (Sickel et al., 
2014). 
There has been research conducted on the specific topic of healthcare providers’ 
stigmatizing views toward individuals with substance use problems, which is not 
surprising given the information about physicians’ generally negative beliefs about these 
patients (van Boekel et al., 2013).  One study examining the attitudes of nurses toward 
these patients showed that, overall, they felt greater acceptance toward them, but a 
minority of the participants still believed these patients were “immoral” and would not 
likely recover from the substance use disorders from which they were suffering (van 
Boekel et al., 2013). 
Generally, a healthcare professional holding stigmatizing beliefs toward those 
with substance use problems can negatively impact delivery of treatment and could 
eventually lead to treatment avoidance or interruption (van Boekel et al., 2013).  
Additionally, negative attitudes held by professionals toward patients with these disorders 
can result in poor communication between the professional and the patient and a 
damaged therapeutic alliance, and can lead the professional to wrongly attribute physical 
symptoms to the patient’s substance use (van Boekel et al., 2013).  Though stigma may 
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not be remedied easily, physicians’ awareness of stigmatized views that are sometimes 
held may lead to better treatment approaches.  
Physicians and substance use disorders.  According to the literature, 25% to 
50% of hospital emergency department visits in urban settings are in some way related to 
alcohol or substance abuse (Lindberg et al., 2006).  With such a large number of 
emergency room visits being related to these disorders, it should come as no surprise that 
individuals with such disorders also present to physicians in nearly all specialties and all 
training levels (Lindberg et al., 2006).  Nevertheless, alcohol and substance use disorders 
are often identified and diagnosed as the result of a patient seeking treatment for another 
problem, such as headache or pain (van Boekel et al., 2013).  Practicing doctors, medical 
students, and residents spend significant time working with these patients, as they 
constitute a large percentage of the medical population (Lindberg et al., 2006).  
Accordingly, healthcare providers are nothing short of essential when considering 
identifying and providing access to treatment options. 
Despite the high frequency with which patients with substance use disorders 
present to all specialties of medicine, there are several issues that can arise when these 
patients and doctors interact.  Miller and colleagues (2001) identified several reasons why 
physicians are underprepared to treat patients who have alcohol and substance use 
disorders.  As mentioned previously, stigma exists among healthcare professionals when 
treating patients with alcohol and substance use disorders.  To make matters more 
complex, research has shown that there are deficiencies in the amount of time spent on 
these disorders in United States medical schools, especially when considering how 
common the disorders are in the general population (Miller et al., 2001).  Other barriers 
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when considering changing the attitudes and practices of physicians in regard to treating 
alcohol and substance use disorders include physician denial that addiction is a “brain 
disease” and not a moral choice one makes, a lack of political support and physician 
advocacy in response to public concern, and physicians having a personal and/or family 
history of drug or alcohol problems (Miller et al., 2001).  
Interestingly, research has shown that physicians and medical students can feel 
intimidated by attempts to be educated and trained about these disorders (Miller et al., 
2001).  A potential reason for these feelings may be any alcohol or substance use issues 
experienced by the practitioners themselves.  One 2016 study found that nearly one third 
of medical student participants met criteria for either alcohol abuse or alcohol 
dependence (Jackson, Shanafelt, Hasan, Satele, and Dyrbye, 2016).  Literature suggests 
that physicians having to learn about, diagnose, and treat substance use disorders may 
bring to the surface denial of their own disorders.  Consequently, for similar reasons, 
physicians may be resistant to diagnosing and treating the disorders in their patients 
(Jackson et al., 2016).  Recommendations from one study included addressing the 
attitudes of medical professionals toward substance abuse in order to create change in 
substance abuse within the greater population (Jackson et al., 2016).  Therefore, it can be 
presumed that, in order to treat patients diagnosed with alcohol or substance use disorders 
effectively, a physician must address his or her own attitudes toward the disorders.  
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Chapter 3: Method 
Overview 
There has been relatively little research conducted on how cardiologists address 
alcohol and substance use with adolescents and young adults who have heart rhythm 
disorders.  The goal of the current study was to increase understanding about the clinical 
practice of cardiologists treating adolescent and young adult patients.  To evaluate the 
perspectives of the cardiologists, an interview format was used.  
The current study focused on cardiologists and their beliefs and practices 
regarding alcohol and substance use among their adolescent and young adult patients 
with LQTS and other heart rhythm disorders.  The study aimed to explore the degree to 
which they address alcohol and substance use with their patients, and the cardiologists’ 
perspectives regarding who holds responsibility for addressing this topic.  Also examined 
was whether the child’s parent is present during such discussions, what the cardiologist 
recommends, and any themes occurring throughout participant answers.  Additionally, 
methods of assessment and intervention used by the cardiologist, as well as the 
preference for and level of integrative care used by the cardiologist were explored.  
Generally, qualitative research focuses less on an event specifically, and more on 
how it occurs, the facets that comprise it, and the effects it has (Tetnowski & D’Amico, 
2001).  According to Baxter and Jack (2008), multiple sources of data allow the 
researcher to study the phenomenon through a variety of lenses while also ensuring that 
many aspects of the occurrence are revealed and understood.  
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Design and Justification  
The study utilized a qualitative research methodology, which led to the 
development of themes that explain the phenomena of interest (Kazdin, 2003).  A 
qualitative design was used to understand the perspectives of the cardiologists treating 
this particular population of patients; the purpose of this type of study design was to 
examine participants’ experiences without restrictions and assumptions (Kazdin, 2003).  
Cardiologists completed an interview with the investigator by telephone.  Participants 
openly discussed their experiences treating patients with heart arrhythmias and the 
manner in which they have approached the topic of alcohol and substance use in the past, 
or how they believe the topic should be approached.  Additionally, their views on 
collaborative care were explored. 
Grounded theory, a method of qualitative research analysis, aims to create 
hypotheses rather than to test previously established ones (Auerbach & Silverstein, 
2003).  Grounded theory allowed the investigator to utilize concepts and ideas coming 
from the cardiologist interviews in order to glean a better overall image of their 
experiences.  The study utilized a semi-structured interview method to examine and 
describe the experiences of cardiologists who treat heart rhythm disorders.  After certain 
themes and ideas were derived from the data analysis, an applicable theory emerged that 
allowed the experiences of the population at hand to become more evident.  The 
grounded theory method employs a data analysis protocol termed theoretical coding, 
which is used to create hypotheses based on what the participants of the study indicate 
(Auerbach & Silverstein, 2003).  An integral component of grounded theory is the 
relevance of the theory created to the experiences of those who are in situations similar to 
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the participants of the study; this relevance leads to credibility of the research and is vital 
to qualitative analysis (Wagner, Lukassen, & Mahlendorf, 2009). 
Despite the significant literature addressing the medical impact that heart 
arrhythmias can have on a person, there is less research addressing potential 
developmentally-specific lifestyle modifications a patient may need to make.  
Additionally, there is a void in the literature surrounding the manner in which physicians 
approach discussing these potential modifications with their patients, as well as 
physicians’ perceptions of this discussion in a more general sense.  The limited range of 
psychosocial research on how alcohol and substance use are addressed within this 
specified population may broaden based on the results of the current study.  
The questions comprising the interview included open-ended questions and 
additional prompts assessing demographic and background information and cardiologist 
experiences.  The study explored various aspects of how cardiologists address alcohol 
and substance use with this population, including (a) whether the cardiologist addresses 
the topic in general, (b) the context and nature of a potential conversation he or she may 
have, (c) whether the patient’s parent is present during this conversation, (d) the 
cardiologist’s belief about who should be addressing these issues with the patient, and (e) 
what the cardiologist recommends for the patient (i.e., abstinence versus moderated use, 
type of treatment plan implemented, etc.).  The questions also aimed to explore 
participants’ general views and attitudes about alcohol and substance use.  
Data Analysis 
 The methodology chosen for the current study was grounded theory, which was 
created by sociologists Glaser and Strauss (1967, as cited in Glaser & Holton, 2004).  
ADDRESSING DRUG USE WITH YOUNG CARDIAC PATIENTS 36 
 
When compared to previously established analysis techniques, grounded theorists 
believed that theories should be rooted in data coming from the field, including in the 
actions, interactions, and social processes of human beings (Corbin & Strauss, 2008).  
Grounded theory allows researchers to construct theory by analyzing data collected from 
participants in a study; these data could include participants’ observations, experiences, 
and various processes (Creswell, Hanson, Clark Plano, & Morales, 2007).  Grounded 
theory allows the researcher to gather information from the participants in the study in 
order to create a hypothesis relevant to the information; this process is called hypothesis-
generating research (Auerbach & Silverstein, 2003).  
 Grounded theory employs a process of hypothesis generation called theoretical 
coding, which follows a multi-step process to draw from data and highlight ideas and 
themes, which are then used to produce and develop a hypothesis considered crucial to 
the research question and phenomena being examined (Auerbach & Silverstein, 2003).  
The coding team for this study included the investigator and two other advanced graduate 
students, all of whom were supervised by a licensed psychologist with experience in 
qualitative methodology.  
The initial review of the participant responses consisted of each coder engaging in 
process note-taking, or memoing, from which he or she gained insight into developing 
ideas and generated initial hypotheses about the participants’ experiences and beliefs in 
regard to addressing alcohol and substance use in their patient population.  According to 
Glaser and Holton (2007), memoing will “present hypotheses about connections between 
categories and/or their properties and begin to integrate these connections with clusters of 
other categories to generate the theory” (p. 63).  Memoing was used in this study in order 
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to assist the coders in making connections between the raw data and the phenomenon 
being explored (Birks, 2008).  The initial review of the participant responses enabled the 
coders to understand experiences from the perspectives of those being interviewed 
(Corbin & Strauss, 2008).  By coding the data and exploring information garnered from 
it, research questions and insights were able to be generated (Auerbach & Silverstein).  
Coding strategies utilized included open coding, axial coding, and selective 
coding.  Beginning with the open coding technique, researchers examined the data and 
coded them for major themes.  From this step, researchers implemented axial coding, in 
which the researchers identified at least one of the open coding categories, called the core 
phenomena (Creswell et al., 2007).  Lastly, in selective coding, the researchers took the 
created model and developed hypotheses based on connecting the categories in the 
model, describing the relationship between the categories (Creswell et al., 2007). 
 These steps were implemented by the investigator and two additional individuals, 
in order to achieve triangulation.  Each coder reviewed participant responses, exploring 
and highlighting relevant ideas and, ultimately, generating an initial theory (Auerbach & 
Silverstein, 2003).  Within the scope of grounded methodology, sample size is unknown 
initially because the researcher needs to continuously add new information to the theory 
by gathering more data from participants (Auerbach & Silverstein, 2003).  Theoretical 
saturation, which indicates that the sample size is sufficient and appropriate, was reached 
when new information was no longer recognized and information began to repeat itself 
(Auerbach & Silverstein, 2003).  Ultimately, the coding team agreed upon the evaluation 
of the themes and interpretations of the data in order to produce accurate results.       
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Participants 
The participants in this study consisted of five cardiologists who provide medical 
treatment to individuals with LQTS and/or other arrhythmias.  Participants included 
cardiologists with varying ranges of experience in treating patients with LQTS or other 
cardiac rhythm disorders.  Additionally, the participants either currently work or have 
previously worked in various states in the United States.  The study data were collected 
via telephone.  The interviews were scheduled at times convenient for both the researcher 
and the study participants.  The interview was conducted by both parties in quiet spaces 
in which interruptions were unlikely.  
Due to the small sample size in this study, variability in the participants’ 
experiences and backgrounds was pursued and appears to have been achieved.  In 
addition, saturation of the data was sought, to ensure a reliable basis for identifying 
themes.  Theoretical saturation is the point in analysis when all categories are well 
developed in terms of properties, variations, and dimensions (Corbin & Strauss, 2008).  
This requirement for qualitative research was met, as several themes were developed 
from the interviews. 
Inclusion criteria.  Participants in this study were required to be cardiologists 
within the United States, including those from within specialized fields, such as 
interventional cardiologists, noninvasive cardiologists, electrophysiologists, pediatric 
cardiologists, and cardiac and vascular surgeons.  As the patient population of interest 
included adolescents and young adults (individuals ages 13 to 24), general cardiologists 
were appropriate participants for the study.  Additionally, the cardiologists must have 
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self-identified as having recent experience treating adolescents and young adults with 
rhythm disorders (within the last two years).  
Exclusion criteria.  Individuals were excluded from this study if they did not 
treat heart rhythm disorders.  They were also excluded from the study if they had not 
treated a patient with a heart rhythm disorder within the last two years.  
Recruitment.  A sample of cardiologists was recruited to participate in this 
research study.  Information about the study was sent in the form of a recruitment letter to 
prospective candidates via mail and e-mail (Appendix A).  Physicians were recruited via 
networking, word-of-mouth, and snowball sampling, which provided the investigator 
with contact information of cardiologist colleagues.  Physicians were also recruited via a 
social media announcement posted to sites such as Facebook and LinkedIn.  Recruitment 
letters were sent to pediatric cardiologists based on contact information listed on the 
Pediatric & Congenital Electrophysiology Society (PACES) website.  According to the 
PACES website, this international group of doctors aims to improve the care of children 
and young adults with heart rhythm disorders.  The group is nonprofit and has a mission 
of exchanging information and ideas about arrhythmias, particularly in young individuals, 
through collaboration and research.  A similar organization, Sudden Arrhythmia Death 
Syndrome (SADS) Foundation, also provides patients and families with a yearly updated 
list of physicians nationwide; the SADS Foundation website was also of use to the 
current study in seeking potential eligible participants. 
Demographic characteristics.  Various demographic questions were answered 
by each participant at the onset of the interview.  The participants were five cardiologists 
including four males and one female.  Additionally, each participant worked in a different 
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state in the United States, varying from the Pacific West Coast to the Midwest to the 
Northeast.  None of the participants had family members diagnosed with LQTS; 
however, two of the five participants identified having family members with arrhythmias 
(one cardiologist’s mother, now deceased, had atrial fibrillation, and another 
cardiologist’s wife has atrial tachycardia).  The table below provides demographic 
information for participants. 
 
 
Table 1 
Summary of Participant Demographic Characteristics 
Characteristic      Participants 
 Dr. 
Alex 
Dr. 
Barbara 
Dr. 
Charlie 
Dr. 
David 
Dr. 
Evan 
Gender 
 
Board Certified 
Male 
 
Yes 
Female 
 
Yes 
Male 
 
Yes 
Male 
 
Yes 
Male 
 
Yes 
Type of Medical School Allopathic Allopathic Allopathic Allopathic Allopathic 
Years of Experience 16 27 15 12 22 
Any Outside Mental 
Health Training 
No No No No No 
Practice Setting Academic 
Children’s 
Hospital 
Outpatient 
Outreach 
Clinic 
Office & 
Inpatient 
Office & 
Inpatient 
Academic 
Hospital 
U.S. State Location 
 
Adolescent/Young 
Adult Children 
WV 
 
Yes 
MI 
 
Yes 
NJ 
 
No 
NY 
 
No 
CA 
 
Yes 
 
Family Member with 
Arrhythmia 
No Yes No No Yes 
Family Member/Friend 
with SUD 
No Yes No Yes No 
Measures 
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A list of interview questions was developed by the investigator as the result of a 
comprehensive literature review and collaboration with colleagues and mentors. The list 
of questions was reviewed carefully by individuals with expertise in the areas being 
examined and only necessary and relevant questions were included (Appendix B).  The 
semi-structured interview consisted of specific questions, open-ended questions, and 
background and demographic questions.  It also included additional prompts used by the 
investigator.  The questions were not always asked in order; however, each participant 
was asked the same core questions.  The interview consisted of questions related to each 
cardiologist’s approach to addressing alcohol and substance use with his or her 
adolescent and young adult patients.  The interviewer also gathered personal information 
about the participants, such as their gender, number of years of experience with the 
population of interest, whether they have family histories of LQTS, and whether they 
have had additional psychological training. 
Procedure 
The population of interest was solicited through the PACES and SADS 
Foundation.  Participants were also solicited by e-mail with a letter gauging interest in 
participating in the study.  Potential participants were presented with a brief description 
of the purpose of the study in the e-mail they received.  Members of PACES and SADS 
Foundation were also able to read a brief description of the purpose of the study in an     
e-mail, which was sent to each member.  By reading the brief introduction and agreeing 
to participate, participants provided informed consent.  All interviews were recorded on a 
digital recorder.  After each interview was complete, the investigator transcribed all 
recordings.  Transcribing each interview allowed information to be extracted via a 
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functional form for analysis of the data, and ensured that the information gathered from 
the interviews was accurate and consistent.  Pseudonyms were created and used during 
the coding process to maintain the participants’ anonymity.  All collected data were 
password protected and remained confidential; no identifying information was retained 
from participants.  After each interview was recorded and transcribed, it was deleted 
completely. 
After the interviews were transcribed, the coding team reviewed the transcripts for 
common themes.  A coding scheme was created to define themes that emerged from the 
information collected during the interviews.  The coding team met on multiple occasions 
to discuss impressions of the data and reach agreement on the topics identified.  The 
investigator then interpreted the themes generated from the transcripts and, subsequently, 
developed a theory relating to those themes.  The themes were explored and linked to 
existing research.  Specific quotations from the participants were utilized in order to best 
demonstrate the meaning of the common themes that emerged, and to provide a voice for 
cardiologists who work with the population of interest.  All participants were given a $10 
gift card toward Starbucks Coffee. 
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Chapter 4: Results 
In the current study, the experiences and beliefs of cardiologists treating 
adolescent and young adult arrhythmia patients were examined.  Analysis of the data 
collected resulted in emergent themes: patient presentation, parental presence, external 
influences, communication factors, and responsibility. 
According to the literature, physicians are guided by their own individual set of 
heuristics; therefore, even if two physicians emphasize the same component of a medical 
problem, one may perceive it as more important than the other (Mancuso & Rose, 1987).  
Participants in this study were asked about their decision-making process in regard to 
addressing alcohol and substance use with their patients; specifically, they were asked 
about what may trigger them to approach the topic with a patient, and what influences 
their approach.  
Participant responses varied significantly in this context.  Although all five 
participants stated that they address alcohol and substance use with their patients, the 
frequency with which such a discussion occurs varied across participants.  Some 
participants shared that they address the topic with their patients routinely, eliminating 
the need to utilize any decision-making process.  For example, one cardiologist explained 
that he follows a standardized procedure for addressing alcohol and substance use with 
his patients, which begins before he even enters the exam room with the patient.  His 
medical assistants collect information from the patient about alcohol and substance use 
along with other information, such as vital signs, and enters it into the electronic medical 
record so it can be reviewed prior to meeting with the patient. 
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Other cardiologists referenced using a standard form or questionnaire that is given 
to patients at the onset of each visit.  One participant stated that he addresses alcohol and 
substance use with a new patient on the first visit, but infrequently addresses it in 
following visits.  Overall, participants acknowledged several factors they are influenced 
by in regard to addressing the subject of alcohol and substance use with patients.  
Patient Presentation 
Patient symptoms.  Patient symptoms led to physicians addressing high-risk 
behaviors thoroughly.  One cardiologist cited heart palpitations, shortness of breath, or 
chest pain as symptom “triggers” that would lead him to address the topic.  Several 
participants explained that they “dig deeper” and inquire more thoroughly about alcohol 
or substance use if it is apparent that the use is contributing to the reason the patient is 
being seen.  For example, one cardiologist explained the circumstances of a former 
patient who would present with cardiac symptoms several times per year following 
episodes of heavy drinking.  
Physicians mentioned that they tend to generally address various factors that 
could induce symptoms.  For example, one cardiologist explained that he will address 
“things that could trigger an arrhythmia,” which not only includes drugs and alcohol, but 
physical activity such as competitive sports.  A common theme emerged that 
cardiologists feel either more comfortable addressing alcohol and substance use, or more 
likely to address it, if they believe that a patient’s use could be contributing to his or her 
current cardiac issues.  Interestingly, one participant noted that he typically will broach 
the subject on the first visit with a patient and only bring it up in the future “if it’s a 
recurring issue:” 
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If I saw that there might be, you know, something that is contributing to 
why they're seeing me, or their symptoms or whatever. So, you know, I'll 
ask about caffeine and alcohol most commonly with people with 
arrhythmias or palpitations. Otherwise I don't dig too deep if I'm not 
concerned about it sort of from a cardiac standpoint. (Dr. Charlie) 
Patient age/developmental level.  All participants in the current study were 
cardiologists who either currently work with or have worked recently with patients 
between the ages of 13 and 24.  Several of the participants acknowledged their awareness 
of how the patient’s age and/or developmental level typically inform their approach of 
the topic of alcohol and substance use.  For instance, participants referenced the 
prevalence of binge drinking and caffeine use within college-age students:  
So with alcohol, questioning in an adolescent or college age students, if 
they said they didn't smoke cigarettes 6 months ago, but now they’re 
coming and/or they didn’t drink alcohol 6 months ago, if they’re coming 
to see me 6 months later, I might re-address: “Oh, just out of curiosity, are 
you drinking wine now or beer or something? Even though you said you 
weren’t 6 months ago?”  Because in that patient population, you know, it’s 
more likely that something has changed, or at least statistically, binge 
drinking is very common in college-age students.  Or in some cases with 
caffeine, I may have students who don’t normally drink caffeine, but when 
midterms come they’ll say, “Oh, I have midterms,” and when I hear 
someone’s studying for exams I think, “Well I wonder, are you now 
drinking a lot of coffee while studying for your exams?” which is sort of 
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episodic, once every 6 months, “and is that causing you to have chest pain 
or insomnia or palpitations?” (Dr. David) 
Generally, participants demonstrated knowledge and awareness of developmental 
level when considering their approach to addressing the topic of alcohol and substance 
use with their patients.  The prominence of binge drinking habits, caffeine consumption, 
and recreational use of stimulant medication was acknowledged in many of the 
cardiologist interviews.  Dr. David explained that, with a patient who is in his or her 60s, 
he likely will not address the topic of alcohol use or cigarette smoking continuously.  In 
contrast, for a college-age patient, he will continue to address the topic, as “it’s more 
likely that something has changed” with a college-age patient versus an older patient who 
has longstanding habits. 
Physicians also acknowledged patient developmental age by speaking about peer 
pressure and social situations.  The presence of peer pressure, pressure to “fit in,” and the 
occurrence of potentially difficult social situations in an adolescent or young adult’s life 
appears to heavily impact the decision of the physician to address the subject of alcohol 
and substance use.  Dr. Alex detailed what he might say to a young patient: “I would say, 
‘It’s okay if you want to fit in and you want to grab a beer or whatever, that’s fine, but for 
you to get sloshed and blackout drunk is not a good idea.’”  Later in the same interview, 
Dr. Alex said in regard to college-age patients: “You have enough pressure fitting in and 
you don’t want to add another problem.” 
Dr. Evan spoke of the idea that adolescents tend to view themselves as immortal 
or invincible.  Although this is a widely held belief, some of the literature disputes it.  
The terms “optimistic bias” and “perceived vulnerability” are often mentioned in these 
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data and refer to the concept that adolescents’ perceptions of risk are skewed (Reyna & 
Farley, 2006).  Research shows that, when compared to adults, children and adolescents 
have less ability to delay gratification, inhibit their behaviors, anticipate the future, think 
of consequences spontaneously, or learn from negative consequences (Reyna & Farley, 
2006).  Additionally, they tend to view consequences as being less harmful than adults do 
(Reyna & Farley, 2006).  Nevertheless, it has been shown that adolescents do not 
perceive themselves to be invincible, and perceived vulnerability declines with age 
(Reyna & Farley, 2006). 
Parental Presence 
Studies have shown that, within patient-parent-physician encounters, parents tend 
to interfere and offer themselves as the “leaders” of these encounters (Nova, Vegni, & 
Moja, 2005).  This is true for parents regardless of their children’s ages; however, 
physicians are more likely to involve older child patients in these encounters (Tates, 
Elbers, Meeuwesen, & Bensing, 2002).  Moreover, in the patient-parent-physician 
scenario, the physician tends to ask the child directly for information, but excludes the 
child in the discussion regarding the diagnosis or treatment (Nova et al., 2005).  Some 
studies have argued that parents may be to blame for inhibiting their children’s 
participation in medical encounters (Stivers, 2012).  Others have shown that, regardless 
of parent presence, outpatient healthcare providers do not spend an adequate amount of 
time interacting with their young patients (Stivers, 2012).  
Responses varied significantly when participants were asked about whether their 
approach is impacted by the presence of a patient’s parent.  Dr. Alex stated that he will 
“always” discuss alcohol and substance use with his patients, but that he is “less likely” 
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to address illicit drugs if the patient’s parent is in the room.  A 2002 study suggested that 
there are two types of adult behaviors in the context of these types of medical 
interactions: supportive and non-supportive (Tates et al., 2002).  Supportive adult 
behavior refers to the parent and the physician being verbally and nonverbally 
encouraging toward the child, enabling him or her to take an active role in the encounter, 
whereas non-supportive behavior refers to both parties directing the interaction and 
treating the child as a bystander (Tates et al., 2002).  
Two of the five cardiologist participants said that their approach to addressing 
alcohol and substance use is not impacted at all by the patients’ parents being present in 
the room.  Dr. Evan said, “It doesn’t really impact how I say it, depending on the whether 
the parent’s there, because I’ve chosen to do it in a way that, to me, is acceptable to do in 
front of the parents.”  Dr. Evan went on to describe how he believes that his approach 
does not necessarily elicit an “admission” of use from the patient, and that it is more 
focused on educating the patient instead of lecturing or shaming him or her.  Dr. David 
said that his approach is not affected by the presence of the patient’s parent “because it’s 
so important to the clinical perspective” to get the information from the patient, 
regardless of whether the parent is in the room. 
Dr. Charlie stated that he would likely ask the patient’s parent to step out of the 
room “if there’s a high-risk situation.”  Although he did not elaborate on this response, it 
can be inferred that he would use clinical judgment in order to assess whether the 
parent’s presence would have a negative impact on the patient’s treatment.  Dr. Barbara 
indicated that she sometimes feels conflicted when it comes to parental presence.  She 
explained that she is less likely to bring up alcohol or substance use if the patient’s parent 
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is present, but then stated that the parent “could have useful information” or “provide a 
reality-check” if the patient is not being truthful or completely honest about his or her use 
of substances. 
External Influences 
 Data suggest that external influence of mass media is extremely powerful in 
creating societal views and perceptions of drugs and drug use.  In fact, some data 
acknowledge that media is involved in creating “moral panics” and “strong societal 
reactions against certain drugs and drug users” (Montagne, 2011, p. 849).  Research has 
identified “collective social knowledge” as influential in the development and 
communication of perceptions about drugs; social knowledge is defined as the 
cumulative knowing of something, based mostly on available information and past 
experiences (Montagne, 2011).  
From 2000 to 2016, the rate of deaths from drug overdoses increased 137%, with 
a 200% increase in the rate of overdose fatalities from opioids (Rudd, Aleshire, Zibbell, 
& Matthew Gladden, 2016).  In present-day society, the frequent use of the word 
“epidemic” has been associated with the rising rates of the use of opioids, including 
heroin.  The opioid epidemic in the United States has been identified as an “urgent public 
health and public safety crisis;” in 2014, there were 1.9 million Americans abusing 
prescription opioids (Knopf, 2016; Thornton, Lyvers, Scott, & Dwibedi, 2017).  
Additionally, recent legislation legalizing or decriminalizing the medical and 
recreational use of marijuana in some states has been widespread in the media.  Both of 
these contemporary issues were mentioned in the participant interviews and seemed to 
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impact cardiologists’ approaches and decision-making.  Dr. Barbara referenced the opioid 
crisis specifically, and her thought process in regard to her patient population: 
I guess it’s more the media and, you know, you read about all the numbers 
of things.  And you know, you hear about people that are overdosing on 
opioids, or just the impact of marijuana, or that kind of thing, and then you 
think “If these numbers are so high,” and I have thought about this, you 
know, “I’m seeing this many patients this week, chances are, especially in 
that age group, that some of those people walking in are dealing with these 
issues,” is the most statistical standpoint. (Dr. Barbara)   
Data or Statistics 
Four of the five participants in the current study shared that their approach is 
driven by data or statistics.  The statistical information the cardiologists mentioned seems 
to be used to either inform patients about potential risks or to decrease worry in patients 
or their parents.  Research shows that having children with congenital heart diseases can 
be associated with such outcomes in parents as adaptation problems, distress, guilt, and 
reduced quality of life (Lawoko & Soares, 2003).  Learning about various statistical 
information may minimize worry in parents of patients, particularly of those who have 
children with arrhythmias associated with sudden death.  Dr. Alex addressed this and 
described how he often tells his young patients and their parents about statistics regarding 
the risk of dying from having an arrhythmia such as LQTS:  
We’re so afraid, and I get it.  It’s in the newspaper and on the news.  It’s 
devastating, right?  A little 8-year-old kid dies playing soccer, and the 
whole world goes upside down, and it’s very, very sad.  Don’t get me 
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wrong, it’s very, very sad.  But the chances of that happening . . . there’s 
about 500 deaths per year in America from unrecognized things, like long 
QT, in athletes.  So 500 kids a year, that’s a boatload, but not when you 
consider how many millions of baseball games, basketball games, soccer 
games, or whatever, are played per year in America.  Five hundred is 
pretty low, right?  But we make a huge deal out of that, yet 15,000 
teenagers die a year in cars.  It’s actually higher than 15,000.  But there’s a 
much, much greater risk of your kid dying when they get into a car and 
they’re a teenager, than your kid with long QT ever dying. (Dr. Alex) 
Dr. Alex also described informing the patient and the patient’s parent about how 
the knowledge of the patient’s diagnosis can decrease statistical risk of dying from 
sudden death.  For example, he will tell a patient with LQT1 and his or her parent that 
there is a 10% chance of sudden death with that particular disorder, and that the risk of 
sudden death decreases to 1% once a diagnosis is made and the patient is put on 
medication.  When managing an illness that carries high levels of uncertainty, being 
informed of statistical information may be tremendously comforting to a patient and his 
or her family.   
Other cardiologists insinuated that they feel more comfortable addressing alcohol 
and substance use with patients and their families if they are well-informed about 
statistics and data regarding the particular substance.  Dr. Barbara said, “There’s a lot of 
data about cigarette smoking, so I’m pretty comfortable saying ‘Cigarettes hurt your 
lungs, but they also hurt your heart and make you at risk for future heart problems.’”  Dr. 
Evan explained, “I do tell [patients] how concerned I am about binge drinking, and not 
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even because binge drinking is bad, it’s because binge drinking is certainly associated 
with some arrhythmias.” 
In the context of data and statistics, it is noteworthy to discuss the opioid 
epidemic and its impact on how physicians approach the topic of alcohol and substance 
use with their patients.  Of particular interest is the state of West Virginia, where Dr. 
Alex practices, which had the most deaths from drug overdoses in 2015 out of all 13 
states considered part of the cultural area of Appalachia (Thornton et al., 2017).  The year 
prior, West Virginia had the highest rate of overdose deaths in the entire United States 
(Rudd et al., 2016).  Dr. Alex acknowledged the high frequency of opioid use in West 
Virginia and insinuated that this knowledge impacts the way he approaches patient drug 
use.  Dr. Alex said, “Unless I have something that triggers me, I don’t have a routine 
conversation about cocaine.  And really, in this state, it’s opioids.” 
Clinical Experience 
 Several cardiologist participants recognized that their approach is informed by 
clinical experience, which varied in years across participants, with a range of 12 to 27.  It 
seems as though clinical experience is a generally positive influence on a cardiologist’s 
approach; it allows the physician to go through somewhat of a “trial and error” 
experience, enabling him or her to learn about which approaches are most efficacious.  
Dr. Charlie noted the trial and error process, saying, “I think that it takes time, and some 
of it is experience, and just taking what works and doesn’t work.”  
Dr. Evan, who works primarily with adolescent patients, shared that his clinical 
experience has led to a better understanding of teenagers in general.  He mentioned 
fellows and residents with less experience, explaining that the less-experienced doctors 
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will remark on his approach and its efficacy, and that they learn from him.  Dr. Evan also 
spoke about his observation that residents are often hesitant to address alcohol and 
substance use on each visit, saying, “Well, we’ve talked to [the patient] about that,” and 
Dr. Evan will respond by saying, “No, you have to talk about it every visit.”  This was 
another aspect of clinical experience that seemingly impacts an approach taken with 
patients.  
Communication Factors 
Overview.  The way in which a doctor communicates with his or her patient can 
impact many factors, including physiological measurements, adherence to treatment 
recommendations, and general satisfaction with medical care (Pantell, Stewart, Dias, 
Wells, & Ross, 1982).  Research has shown that physicians tend to underestimate their 
patients’ desire for information, overestimate how much information they give to their 
patients, and give variable amounts of information based on a patient’s level of 
education, income, gender, and age (Street, 1991).  Research has also found that patients 
who are more seriously ill will generally receive more information from doctors than 
those who are not as seriously ill (Street, 1991).  Communication between patient and 
physician is critical, especially when addressing chronic illnesses. 
When considering physician-patient encounters with younger individuals, direct 
communication is of particular importance.  It builds trust and rapport and is highly 
valued by young patients (Stivers, 2012).  Furthermore, studies have shown that children 
are interested in clinical information and can actually retain some information better than 
their adult counterparts (Pantell et al., 1982).  One study suggested that the physician 
talking more extensively with the young patient led to better parent satisfaction and 
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adherence to treatment by the patient’s parent (Pantell et al., 1982).  Patient-physician 
communication was a commonly referenced theme throughout the interviews in this 
study.  Physicians were asked about specifics regarding their communication with 
patients and parents, including the language they tend to use and their preferred 
communication styles.  
Realistic approach.  Three of the five participants in the study acknowledged 
that they take a “realistic” approach when addressing the topic of alcohol and substance 
use with patients.  Dr. Evan explained, when discussing what he recommends to his 
adolescent and young adult patients in regard to alcohol and substance use, “I certainly 
don’t talk to them about abstinence because that’s kind of ridiculous.  I just try to get 
them to understand what my concerns are.”  Regarding abstinence, Dr. Alex said, “[it] is 
just not realistic.” 
Several of the participants spoke about the concept of moderation and how 
strongly they believe in encouraging the patient to practice moderation rather than 
complete abstinence when using alcohol or substances; however, the suggestion of 
practicing moderation did not always apply to every substance.  For example, Dr. Alex 
explained that he recommends to patients to never drink energy drinks with high levels of 
caffeine, such as Red Bull, Monster, or 5-Hour Energy, but that he believes it is 
acceptable for the patient to drink caffeinated beverages, such as sweet tea or soda, if it is 
consumed in moderation.  Dr. Alex recommends that while at home, the patient drink 
only decaffeinated beverages, but if the patient is out with family at a restaurant, he or 
she can have a caffeinated beverage.  He does not tell his patients explicitly how many 
caffeinated beverages they should limit themselves to.  
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Cardiologists also seemed to integrate their knowledge of the patient’s 
developmental phase into striving toward a realistic approach of the subject of alcohol 
and substance use.  Several cardiologists referred to putting an adolescent or young adult 
“in a bubble” and how doing so can be detrimental.  Participants also often used the word 
“normal” and seemed to strive to take not only a realistic approach with patients, but an 
approach that will minimize patients’ feelings of being different or “other.”  Dr. Alex 
said, “I’ve seen kids put in bubbles, and I have to tell you, when they come in, they’re 
just not right.”  He explained his belief that if a young patient is restricted excessively, he 
or she will not be capable of functioning properly in society.  
Passive approach.  Two of the five cardiologists described their somewhat 
passive approaches.  When asked about a specific patient who had been struggling with 
alcohol use issues, one cardiologist said that she is “not in the habit of quantifying 
[patient alcohol consumption]” and insinuated that she typically becomes aware of a how 
much of a substance a patient is consuming only if he or she is forthcoming or volunteer 
the information. 
When Dr. Charlie was asked about how he would approach a patient who was 
vehemently denying using despite the patient’s use being quite blatant, he described how 
he may say, “Are you sure you’re not drinking?” or “Are you sure you haven’t used 
cocaine in the last week?”  He said, “and if they say no, then, you know, it is what it is.”  
The passive nature of the cardiologist’s approach and using the phrase “it is what it is” 
could be due to several factors, including feeling underprepared or ill-equipped to address 
the issue further.  The passivity could also be due to fear of confrontation which, in some 
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cases, could result in a strained patient-physician relationship, or even cessation of 
treatment with that provider.  
Within the context of taking a more passive approach with patients, the issue of 
documentation was introduced during the participant interviews.  More specifically, one 
cardiologist expressed her reticence to address certain aspects of patient alcohol or drug 
use because of the need to subsequently document them in the patient’s electronic 
medical record: 
I think the documentation piece is also a bit of a potential problem.  In the 
old days there were records that people rarely saw, but nowadays, if 
people are in fact looking, and I’m looking at the letter you wrote and see 
“the person’s drinking four days a week,” I wouldn’t like that to be in my 
record.  They may not want things disclosed.  It’s one thing to see it in 
writing.  You put something in a record and it just stays on there forever.  
It’s on a problem list, and then it’s stuck. (Dr. Barbara) 
 Dr. Barbara’s approach seemed to be guided partially by an avoidance of 
potential patient pushback or rupture of the patient-physician relationship.  Since 
2009, the number of hospitals utilizing electronic medical records (EMRs) has 
tripled, and almost half of all hospitals now use them (Guttmacher & Tiersten, 
2014).  The utility of an EMR is rooted in the idea that it can become a hub of 
information for all of the medical providers involved in a patient’s care; however, 
there are some drawbacks.  A provider may be fearful of putting some 
information about a patient into the record that might lead to misunderstandings, 
or even legal action, if that information is misinterpreted (Guttmacher & Tiersten, 
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2014).  In some cases, including in the case of the aforementioned cardiologist, 
physicians may refrain from entering information into EMRs due to the potential 
drawbacks, which can impact patient care negatively (Guttmacher & Tiersten, 
2014).  Having positive rapport between patient and physician is extremely 
important; however, it could be argued that purposely omitting information from a 
patient’s EMR is unethical.  Furthermore, omitting certain information from a 
patient’s record may actually impede the patient’s recovery and, in some cases, 
create more frustration or stress for other providers.  
Viewing the “Big Picture” 
Another common theme discussed by participants was the idea of viewing the 
patient and the patient’s life from a “big picture,” holistic perspective.  More specifically, 
several of the participants took into consideration their patients’ social lives, education, 
and quality of life.  For example, one cardiologist discussed his approach when working 
with athletes who have arrhythmias.  He described working with a college cheerleader 
diagnosed with LQTS, who he cleared medically so she could continue to participate in 
her sport.  He explained that part of his treatment approach with her takes into 
consideration the fact that it is more likely to develop medical comorbidities by being 
sedentary than by being active.  Moreover, he explained, the chances that a patient will 
develop obesity as a result of inactivity are higher than the chances of a patient dying 
from a sudden cardiac event while playing sports.  
An interesting aspect of the “big picture” approach taken by several of the 
participants included considering the potential consequences of restricting patients from 
engaging in certain activities.  For example, one cardiologist explained his experience 
ADDRESSING DRUG USE WITH YOUNG CARDIAC PATIENTS 58 
 
with a patient who resided in an inner city area and earned a college scholarship to play 
basketball.  He shared about how his thought process included imagining what the 
patient’s life would be like if he were not medically cleared.  The cardiologist said, 
“there’s a much, much greater chance of him dying by not going to [X University], or not 
going to school, than whatever the risk is playing basketball.”  
Taking this type of empathic, patient-centered approach may indicate to patients 
that their physicians truly care about their overall well-being, rather than only their 
symptoms or diagnoses.  The literature shows that this type of empathic expression can 
be beneficial for patients and, in turn, society, in many ways.  The effective 
implementation of empathic communication can improve patient adherence to treatment, 
which leads to improvement in patient health and can lead ultimately to reduction in the 
economic costs often caused by frequent changing of doctors and malpractice lawsuits 
(Kim, Kaplowitz, & Johnston, 2004). 
Guilt- or Shame-Inducing 
Participants were asked to describe exactly what they may say to patients who 
admit to using alcohol and/or substances.  Several of the participants explained that they 
tend to take a nonjudgmental approach or an approach that is driven by wanting to 
educate patients rather than “lecture” them.  Some research has shown that an approach 
focusing on patient empowerment, one in which the physician is viewed as a resource, is 
most successful in assisting patients in making decisions.  In particular, one study 
supported this approach when sharing negative information with adolescents and their 
families in regard to chronic illness (Karnieli-Miller & Eisikovits, 2009).  Others have 
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shown that a more directive approach is more successful with some patients (Cohen & 
Britten, 2003).  
Although participant responses in this domain varied, a common theme emerged 
indicating that physicians sometimes feel unequipped to handle situations in which their 
patients admit to using drugs or alcohol despite being aware of the potential risks.  One 
cardiologist said, “Other than sort of telling them [the patient] the risk of continuing, I 
don’t really feel equipped.”  Research suggests that training within medical school 
curricula is often inadequate and, at times, nonexistent.  Thus, it is unsurprising that 
medical students and doctors often lack competency in assessing and managing alcohol 
and drug health problems effectively (Cape, Hannah, & Sellman, 2006).    
Research has shown that physician interactions often result in patient shame 
(Harris & Darby, 2009).  Individuals who experience shame in a medical context can 
attribute extremely adverse consequences to the interaction, including distress, cessation 
of treatment, and lying to the physician in future encounters to avoid feeling embarrassed 
(Harris & Darby, 2009).  On the other hand, some patients interpret shame-inducing 
remarks by their physician to be helpful (Harris & Darby, 2009).  Interestingly, one study 
suggested that participants identifying smoking, alcohol use, or drug use as the source of 
feelings of shame tended to think physicians were helpful and even admirable, but were 
also more likely to lie to physicians during future visits (Harris & Darby, 2009).  One 
participant described taking an approach that could be considered guilt or shame-
inducing. 
I tell them, “You’re lucky enough to be alive, you’re lucky enough to 
know what your diagnosis is, you’re lucky enough to receive treatment for 
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that diagnosis . . . do you really want to add another issue on top of it like 
lung cancer or COPD?”  And if it were congenital heart disease . . . I have 
an adult who is 34 and they survived the transposition of arteries or 
something like that . . . tetralogy of Fallot . . . into adulthood.  “You’re 
here, right?  You’re 34 . . . you’re lucky to be here and you survived 
tetralogy of Fallot.  Do you really want to have to deal with lung cancer?” 
. . . for example.  Or in the case of obesity, I do the same thing for obesity, 
right?  I’ll say, “You’re alive.  Do you really want to have diabetes, 
coronary artery disease, stroke . . . on top of what you’ve already 
survived?”  So that’s the approach that I use. (Dr. Alex) 
 Although this type of message could induce guilt or shame, it appears that 
the impetus behind it is to support the patient and let the patient know that he or 
she is cared for.  One cardiologist participant, who appeared to take a similar 
approach, said that he says to patients, “You just don’t want to have to deal with 
the additional issues” of using substances.  This indicates a level of empathy from 
the physician that may be interpreted positively by the patient.  Additionally, it 
seems as though a guilt- or shame-inducing approach was connected to 
cardiologists’ desire for their patients to feel as “normal” as possible.  While 
discussing his approach to patients who admit to using substances, one 
cardiologist said, “I don’t want to deprive the kid . . . a significant part of my 
practice is helping children and, more, honestly, families and parents . . . treat 
their kids like a normal kid.”  
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Relating to/Aligning with the Patient 
Cardiologist participants often referenced the fact that they have experienced 
adolescence and young adulthood, along with the factors that impact individuals in those 
age ranges, and used it as a part of their approaches.  Cardiologists used statements such 
as “I’ve been there,” “I’ve gone to college too,” or “I can understand” while speaking to 
patients.  Additionally, three of the five cardiologist participants disclosed that they have 
adolescent or young adult children.  This additional form of connection between 
physician and patient could result in the physician approaching the subject in a more 
personal manner.  One participant disclosed during the interview that he has a congenital 
heart defect.  He shared his belief that he would be “hypocritical” if he were to tell a 
patient not to do something that he has done.  
Cardiologist participants referred to using age-appropriate language when 
discussing alcohol and substance use with their patients.  Data suggest that children and 
young people dislike when providers use high-pitched vocalization, also known as 
“singsong” (Howells & Lopez, 2008).  One participant described how he uses age-
appropriate, casual language with his patients without trying to “sound like a teenager.”  
Another common theme throughout the cardiologist interviews was relating to 
patients by referring to things familiar to them.  This was particularly evident in one 
cardiologist interview while discussing patient recommendations for consuming energy 
drinks.  Dr. Alex said, “nothing good comes from Red Bull, you know, nothing good 
comes from Red Bull or Full Throttle or Monster.  So I do pick on those, I do name them 
by brand, because that’s what they know.” 
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Informing of Risks 
Participants spoke about risk frequently when discussing their approaches to 
addressing the topic of interest with their patients.  Information exchange signifies the 
type and amount of information that is exchanged between the physician and the patient, 
and whether the information flows one way or both ways (Charles, Gafni, & Whelan, 
1999).  The types of information that the physician may impart to the patient include the 
benefits and risks of various treatment alternatives (Charles et al., 1999).  Three of the 
five participants in the study said that they inform their patients of the potential risks, 
outcomes, or consequences of alcohol and substance use, particularly in relation to their 
cardiac status.  One participant specified that he not only informs the patient of the 
potential risks of using, but also the potential impact using will have on the medications 
he or she is taking (e.g., a blood thinner such as Coumadin).  Risk was also discussed 
when cardiologists spoke about connecting with their patients’ other providers.  For 
example, one cardiologist said that he will be in contact with a mental health provider if 
their shared patient’s psychiatric medication could have a potential impact on his or her 
cardiac status.  
Responsibility 
Participant responses varied when discussing responsibility of informing, 
addressing, and following up with patients regarding alcohol and substance use.  
Participants were asked various questions surrounding responsibility based on their 
previous responses to interview questions.  Overall, participants identified multiple 
sources when discussing who is responsible for addressing alcohol and substance use 
ADDRESSING DRUG USE WITH YOUNG CARDIAC PATIENTS 63 
 
with patients.  Also in the context of responsibility, a theme that emerged was 
responsibility in relation to advocating for patients and patient education and knowledge.   
Other providers.  The most commonly referenced source when cardiologists 
were asked about responsibility was the primary care physician (PCP).  Even one 
cardiologist, who tended to put more emphasis on the patient having responsibility, 
acknowledged that the patient mostly needs to be responsible so he or she can inform 
other providers of his or her illness or symptoms if necessary.  Although many of the 
participants identified that part of their own responsibility includes addressing alcohol 
and substance use, they also frequently spoke of referring to patients’ PCPs. 
One cardiologist seemed to have conflicting thoughts regarding this subject; she 
acknowledged that although she feels partially responsible for addressing the topic, she 
tends to refer patients to their PCPs to address the issue more thoroughly.  She stated, 
“It’s a bit of a black hole,” because she is aware of how irregularly patients visit their 
PCPs.  Another cardiologist suggested that he places responsibility on the patient’s 
“pediatrician or PCP” to address psychological issues, such as depression or anxiety.  
A common theme that emerged throughout the interviews included an emphasis 
on referring the patient to his or her PCP if it is believed that the patient is struggling with 
more serious alcohol or substance issues, or with serious psychological issues, that may 
be beyond the cardiologist’s scope of competency.  Cardiologists were asked during the 
interviews whether they have ever had a patient who was seeing an outside provider for 
an issue related to alcohol or substance use, and whether they had contact with the 
outside provider.  One cardiologist described recently treating two siblings who both 
struggle with mental health issues.  
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I mean, my approach is usually, I ask the patient about the diagnosis and I 
ask them who they’re seeing, what meds they’re on, and what the follow-
up plan is.  Yeah, that certainly happened yesterday . . . where the kids are 
on Zoloft, and I know one of them has problems with depression and 
anxiety, the other one has problems with anxiety and, and you know, we 
just acknowledge that and make sure that they were taking their meds, and 
I ask them how often they’re seeing them [the outside provider].  I mean, 
my responsibility there is just to make sure that they’re plugged in.  So 
once that’s recognized, I can feel confident that things are being 
addressed. (Dr. Evan) 
Patient and/or parent.  Some participants referred to the patient or the patient’s 
parent holding the responsibility when it comes to remaining informed about the cardiac 
effects of alcohol and substance use.  Also related, some participants placed 
responsibility on patients by questioning them about what they have done in terms of 
finding resources:  
I guess one thing I might say is, “You need to talk to your primary care 
physician about, you know, the resources that might help you with this 
problem,” I guess is what we do.  Or I guess you can ask them, “So what 
are you doing about this problem?” and, you know, turn it around as well. 
(Dr. Barbara) 
 In terms of responsibility, cardiologists also spoke about how parents are 
responsible for various aspects of their children’s care.  As the patient population in this 
study included children under 18, many of the participants’ patients live at home with 
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their parents, consume food and beverages purchased by their parents, and rely on their 
parents to transport them to destinations, purchase their medications, and finance their 
leisure activities.  
As discussed previously, cardiologists referred to “overly restrictive” parents 
when taking a realistic approach.  In terms of discussing responsibility, participants also 
shared about how parents are also partially responsible for making their children’s lives 
as “normal” as possible.  One cardiologist explained that he believes parents “play a huge 
role in all of it:”  
All the kids are great.  But it seems like when the kid gets diagnosed with 
a cardiac issue, even something like a heart murmur or something that can 
be easily managed with medications or lifestyle changes, the parent almost 
makes it so the kid can’t be normal or do things with their friends.  Not to 
say that binge drinking or using drugs is a normal, good thing, but there’s 
some things that kids just need to experience for themselves, you know? 
(Dr. Evan) 
Integrative Model of Shared Decision-Making 
 Treatment decision-making processes and treatment approaches for children, 
adolescents, and young adults with arrhythmias are multifaceted and involve numerous 
factors.  Several themes emerged from this research that provide information about the 
considerations and processes cardiologists implement in their approaches to addressing 
alcohol and substance use with patients.  The themes included patient presentation, 
parental presence, external influences, styles of communication, and responsibility.  Due 
to the fact that treatment decision-making occurs within the framework of the physician-
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patient relationship, many models of decision-making have been recommended based on 
the rights and roles of both parties in gathering and exchanging information, and in 
making treatment decisions (Tariman, Berry, Cochrane, Doorenbos, & Schepp , 2012).  
Some of these models include behavioral decision-making, conflict theory, family-
centered, and paternalistic models (Tariman et al., 2012).  Although the patient-physician 
relationship has shifted internationally from a physician-centered, paternalistic 
relationship to a more patient-centered one, more work needs to be done in order to 
continue to strengthen patient care (Lee & Lin, 2010). 
Makoul and Clayman (2006) proposed what they labeled an integrative model of 
shared decision-making (SDM), which was designed to build upon the existing SDM 
literature.  They pointed out that existing models do not share a cohesive definition of 
SDM; thus, their aim was to create a definition of SDM that was “conceptually sound, 
useful for future research, and applicable to clinical practice” (Makoul & Clayman, 2006, 
p. 305).  In order to achieve this, the researchers extricated specific observable behaviors, 
or elements, and relatively general characteristics, or qualities, and separated them into 
two groups.  The two groups, essential elements and ideal elements, comprise their 
proposed model.  The authors explained, however, that only the essential elements need 
to be present in order to engage in integrative SDM, and the ideal elements are not 
necessary, but helpful in the process (Makoul & Clayman, 2006).  In order to examine the 
current research more closely, it was perceived through a lens of an integrative SDM 
model.   
 Essential elements.  Makoul and Clayman (2006) identified numerous factors 
when outlining the essential elements of integrative SDM, several of which were 
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discussed throughout the cardiologist interviews.  First, the patient and physician must 
define and/or explain the problem that needs to be addressed (Makoul & Clayman, 2006).  
Next, the physician should review options and patients should bring up options of which 
he or she is aware (Makoul & Clayman, 2006).  All five participants in this study 
acknowledged the problem being addressed, alcohol and substance use, and also 
acknowledged options in some form.  Within a framework of integrative SDM, 
physicians and patients should discuss the benefits and drawbacks of the options; this 
discussion is integral because the patient and physician may have different opinions on 
the relative significance of benefits, risks, and costs (Makoul & Clayman, 2006).  This 
was made evident throughout the cardiologist interviews, particularly in the context of 
patient age and/or developmental level.  As mentioned previously, adolescents have 
underdeveloped cognitive maturation, which can lead to skewed perception of benefits, 
risks, and costs.  Many of the participants acknowledged this and seemed to incorporate it 
into their approaches with patients.  
 Cardiologists in this study generally presented options in regard to alcohol and 
substance use.  They were asked about what their recommendations are in regard to 
consumption by their patients and, despite variable specifics, participants all seemed to 
integrate options into their patient approaches.  For example, recommending that the 
patient completely abstain from highly-caffeinated energy drinks while also being able to 
drink caffeinated soda in moderation.  In terms of providing options to patients, 
cardiologists also seem to use fact-based knowledge in order to make those options 
known.  For example, pointing out that the patient has the option to drink alcohol or to 
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abstain, but that the patient should be aware of his or her symptoms when drinking 
socially with friends who do not have cardiac conditions.  
Another essential element within an integrative SDM framework is self-efficacy, 
referring to patients’ ability to follow through with plans or to execute a specified 
behavior or set of behaviors (Makoul & Clayman, 2006).  Although patient self-efficacy 
was not addressed specifically during the cardiologist interviews, cardiologists seemingly 
took into consideration their patients’ abilities when acknowledging their developmental 
levels and ages.  They also referred indirectly to patients’ self-efficacy when pointing out 
the restrictions sometimes put onto them by parents.  Cardiologists appeared to want to 
help their patients strive to achieve self-efficacy by providing them with as much 
educational information as possible.  Furthermore, they promoted self-efficacy by making 
known their desires for each patient to live as “normal” a life as possible.  
In order to assess decision outcomes, it is imperative that physicians and patients 
arrange follow-up appointments (Makoul & Clayman, 2006).  The objective of follow-up 
appointments from an integrative SDM perspective is to check in with the patient and his 
or her family regarding final decisions made after an initial meeting (Makoul & Clayman, 
2006).  In the current study, follow-up was addressed throughout the interviews.  In 
regard to addressing the topic of alcohol and substance use, each of the five participants 
stated that they address it, at minimum, on the first visit with the patient.  One could 
consider the first visit to be a period during which both parties, the doctor and the patient, 
exchange information and, ultimately, the patient can either make a decision or defer a 
decision until a later time (Makoul & Clayman, 2006).  Participants did not state 
uniformly that they continuously address the topic during future visits; however, the 
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initial appointment seems to act as a marker by which the patient and family can decide 
how they would like to proceed.  
Patient values and preferences, another essential element of an integrative model, 
was addressed throughout the cardiologist interviews.  Taking into consideration a “big 
picture” perspective and looking at a patient’s life holistically was a common theme in 
the interviews.  Cardiologists tended to view patients and their lives when considering 
their cardiac symptoms.  As arrhythmias are associated with some lifestyle choices, this 
was not surprising; however, it also introduced a sense of empathy on the part of the 
physicians.  The physicians not only considered other aspects of their patients’ lives when 
approaching the subject of alcohol and substance use, but their patients’ quality of life.  
Ideal elements.  Makoul and Clayman (2006) considered some elements of their 
integrative model “ideal” because, although they may enrich the process of SDM, they 
are more pertinent to some encounters than others.  Ideal elements of integrative SDM 
include unbiased information, definitive roles, presenting of evidence, and mutual 
agreement (Makoul & Clayman, 2006).  In the current study, presenting evidence was 
discussed commonly in the cardiologist interviews.  Cardiologists seemed to favor taking 
a data- or statistics-driven approach when addressing alcohol and substance use with their 
patients.  This could be due to physicians’ level of comfort with addressing less-familiar 
topics, their perceived competency in this realm, or simply their preference for concrete, 
empirically-supported facts.  
In terms of unbiased information, Makoul and Clayman (2006) indicated that 
delivering it may only be appropriate if the patient does not want the physician’s 
perspective (2006).  The cardiologists in this study seemed to be biased in a way that was 
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ultimately beneficial for their patients.  For example, when relating to or aligning with the 
patient, one cardiologist shared that he would explain that he has been through college 
and can, therefore, understand the struggles associated with stressful social situations.  
Interestingly, one cardiologist used his biased perspective as an advantage in order to 
provide hope and decrease worry in patients and their families.  He explained that he has 
had a heart condition since childhood, and that it would be hypocritical for him to inhibit 
a patient from doing something he has done.  When considering unbiased information, it 
is important to note that three of the five cardiologists have children who are of 
adolescent or young adult age.  It could be argued that, because those participants have 
children in the same age range as their patients, it is unlikely that they could deliver fully 
unbiased information. 
Interprofessionalism and Shared Decision-Making 
Building upon an integrative model of shared decision-making in medical 
settings, Légaré and colleagues (2013) proposed an interdisciplinary model called the 
interprofessional model for primary care (IP-SDM).  Their model consists of three levels: 
an individual (micro) level, and two healthcare system levels (meso and macro; Légaré et 
al., 2013).  The model is based on the premise that at least two healthcare professionals 
from different disciplines are in collaboration to achieve shared decision-making with the 
patient, either at the same time or one after the other (Légaré et al., 2013).  In order to 
achieve IP-SDM, there is a stepwise process involved on the individual (micro) level. 
Overall, the steps include (a) a decision endpoint being acknowledged with various 
options, potential risks and benefits being acknowledged, and professionals offering their 
knowledge and understanding with the patient, (b) an “exchange of information” 
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regarding the options, (c) a “values clarification” process by which the patient 
acknowledge his or her values and how those values may impact a decision made, (d) 
consideration of the practicality of the options, (e) making a decision with help from 
different individuals, and (f) supporting the patient so the option has a positive impact on 
the health outcomes the patient values most (Légaré et al., 2013).  
Within the healthcare system, the “meso” level includes healthcare teams and 
organizations, and the “macro” level consists of healthcare policies, social context, and 
professional organization (Légaré et al., 2013).  The healthcare team must develop 
“collaborative communication that is authentic, constructive, and open, so as to foster 
mutual trust and respect among team members as well as between the team and the 
patient” (Légaré et al., 2013, p. 21).  For the macro level of the model to be achieved, 
there must be understanding on the part of healthcare professionals that their roles are 
either cultivated or inhibited by organizational routines (Légaré et al., 2013).  The basic 
underpinnings of this model emphasize the importance of fostering communication 
between individuals throughout the decision-making process in order to share knowledge 
and arrive at a common understanding of the concerns at hand (Légaré et al., 2013).  
In regard to interprofessionalism, cardiologists in the current study responded to 
interview questions addressing their healthcare teams, the typical procedures they follow 
when referring patients to other professionals, and their perspectives on referring patients 
to mental healthcare providers.  Generally, cardiologist responses varied significantly 
when asked about who comprises their healthcare teams and what their referral 
procedures have involved.  
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In the context of cardiologists’ healthcare teams, responses varied due to 
cardiologists practicing at multiple sites throughout the work week.  For example, Dr. 
Alex’s healthcare team consists of himself, a pediatric nurse practitioner, and a registered 
nurse when working in an outpatient setting, and while in the inpatient setting, the team 
consists of himself, other attending physicians, physician assistants, residents, social 
workers, and psychologists.  Dr. Barbara, who works full-time in an outpatient office 
setting, explained that her healthcare team consists of herself and another cardiologist, a 
licensed nurse practitioner, and a sonographer. 
To attain successful collaborative communication between healthcare workers, 
professionals need to be familiar with each other’s expertise, roles, and responsibilities 
(Légaré et al., 2013).  When elaborating further about their healthcare teams, several 
cardiologists exhibited confusion about whether mental healthcare providers are a part of 
their teams and, if so, what the mental healthcare providers’ roles and expertise are:  
So as part of my team, when the kids are in my clinic here, I have a 
psychologist—she’s not a psychiatrist, she’s a psychologist—I don’t . . . 
she might have her master’s in child psychology.  I can call her, like if I 
know I have a new kid with long QT, or she’ll come to my clinic and do 
[an evaluation] right after I’m done.  Then she’ll decide if she needs to 
continue to follow them as an outpatient. (Dr. Alex) 
 Dr. Alex’s hesitation when describing his fellow healthcare team member 
indicates a level of misunderstanding that may be impeding his ability to engage 
in successful interprofessional collaboration.  On the other hand, Dr. Alex stated 
that he routinely refers patients to mental healthcare providers, particularly those 
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who have been newly diagnosed with an illness carrying the risk of sudden death.  
Interestingly, Dr. Charlie was the only cardiologist to bring up the issue of 
accessibility of mental health services due to insurance barriers.  He also 
explained that he has only referred patients to other providers for mental health 
issues “once or twice” in his career.  Dr. Evan, when asked about referral sources 
for mental health issues in patients, said “I would ask the social worker to help 
with that.” 
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Chapter 5: Discussion 
Overall Findings 
Overall, the study’s results indicate that the five cardiologists who treat adolescent 
and young adult patients with arrhythmias address alcohol and substance use.  The 
frequency with which cardiologists address the topic varies, in addition to whether 
parental presence impacts their approaches.  Generally, cardiologists seem to be 
influenced most by their patients’ presentations, parental presence, and external factors.  
When speaking about mental health issues, including alcohol and substance use 
disorders, cardiologist participants tended to take a somewhat self-deprecating stance, 
indicating that they do not address those issues “as much as they should.”  This is an area 
in which a clinical psychologist, or other qualified mental health professional, could 
collaborate with cardiologists to improve coordination of care.  
Research suggests that establishing an effective level of collaboration with other 
disciplines requires skilled judgment by physicians (Peek, Baird, & Coleman, 2009).  
Data from the current study indicated that physicians would be more likely to refer a 
patient for psychological services if resources were more readily available, or if they had 
psychology staff on their healthcare teams.  Physicians feeling “ill-equipped” or 
underprepared to deal with mental health issues was a common pattern amongst 
participants.  One cardiologist said that he requires all patients who receive a diagnosis 
“that carries the risk of sudden cardiac death” to have at least one individual and one 
family therapy session; however, this was not the norm.  
One participant referenced stigmatizing beliefs when asked about this issue, 
saying, “I certainly wish there were more resources in general.  Easier access to referrals, 
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less of a stigma for people that need the help.”  Later in the interview, he said, “I’m sure 
there is a stigma.  Personally, I’m happy for people to get the help if they need it.  I try 
not to really judge when people are actually mentally ill.”  Interestingly, the participant 
with the highest number of years of experience, who also has a family member with an 
alcohol or substance use disorder, seemed to have different views.  She offered her 
opinion in regard to reasons people use despite knowing it is bad for them: 
I think some people have addictive personalities too, and if you don’t have 
that, then you kind of wonder, you kind of scratch your head somewhat.  I 
would want to know, why would anybody do that to themselves?  It’s a 
little bit of a lack of understanding, I think, trying to figure out why. (Dr. 
Barbara) 
Research suggests that taking a “big picture” perspective, or treating the patient in 
a holistic manner, can lead to greater collaboration between mental health providers and 
physicians when caring for patients (Peek et al., 2009).   
Clinical Implications 
The findings from this study have several implications for patients, parents, and 
physicians in regard to decision-making and communication.  In ideal circumstances of 
shared decision-making in medical contexts, the roles and rights of both patients and 
physicians should be defined clearly (Makoul & Clayman, 2006).  Thus, physicians 
should consistently define their roles with their young patients in order to increase 
transparency in the decision-making process.  In the same vein, it is vital for physicians 
and parents to include young patients in the decision-making process.  This can lead to 
cultivating the patients’ sense of self-efficacy and, ultimately, impact their adherence to 
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treatment, satisfaction with treatment, and overall investment in treatment (Tariman et al., 
2012).  It is also essential for physicians to continue to consider their patients holistically 
when making decisions and treatment recommendations, and to include consideration of 
quality of life. 
Due to cardiologists referencing their desire to have easier access to referrals, or 
to have mental health professionals as part of their healthcare teams, it is recommended 
that physicians consult regularly with colleagues in order to embrace the concept of 
collaboration and to create opportunities to receive interpersonal and professional support 
with difficult treatment decisions, especially decisions they feel underprepared to make as 
physicians.  Furthermore, given the importance of effective communication between 
cardiologists, patients, and parents, it is important to integrate enhanced training on 
alcohol and substance use, as well as other mental health issues, early in their careers.  
This study is relevant to the theory and practice of psychology due to the 
information it provides regarding stressors, challenges, and areas of difficulty in 
existence with triadic parent-patient-physician relationships.  When mental health 
professionals including psychologists are present on healthcare teams, they can utilize 
their positions to improve patient adherence to treatment and to improve communication 
between patients and physicians.  Additionally, they can use their positions to provide 
modeling opportunities for problem-solving, advocacy, and shared decision-making 
skills.  
Given the significance of interdisciplinary collaboration, it is of the utmost 
importance that clinicians remain aware of several components of their care with patients.  
Providers must be cognizant of their involvement in macro-level healthcare systems, how 
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to provide support to patients during decision-making processes, and the roles and 
responsibilities of other providers.  Specifically, it would be beneficial for physicians 
within an interprofessional model to maintain awareness of the expertise of mental 
healthcare providers in order to accommodate patient needs.  
Study Limitations 
Based on the nature of the research design, there are several study limitations.  
Some of the limitations of the current study relate to external validity, which assesses the 
confines of the results and how the results will generalize to other settings. 
The sample size for this study was small and homogenous; none of the five 
cardiologists are people of color, and only one of the five is female.  Thus, the 
generalizability of the findings from the study is very limited due to a lack of diverse 
representation.  The specific sample that was used in this study were recruited from the 
PACES and SADS Foundation databases, from hospital and medical centers’ public 
websites, and by word-of-mouth and snowball sampling techniques.  Despite the fact that 
PACES includes a sizeable number of pediatric electrophysiologists, it does not include 
all physicians who treat individuals with LQTS, including adults.  Although many 
cardiologists belong to this society and the SADS Foundation database, the findings from 
the current study may not generalize to cardiologists who vary in region, background, and 
experience. 
Additionally, the small sample size in this study was partly due to a lack of 
responses from potential participants during the recruitment phase.  Letters were sent via 
e-mail and standard mail to over 100 cardiologists over a 1.5-year period and only three 
responded.  The other two cardiologists were recruited by word-of-mouth.  Recruitment 
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announcements were also posted to social media websites including Facebook, LinkedIn, 
and Twitter, which yielded no cardiologist participant responses.  Cardiologists who 
responded to the recruitment attempts may be more passionate about the topic of alcohol 
and substance use.  Therefore, they may feel a sense of personal investment in research 
on the topic, leading them to respond to the recruitment letters.  One such example was 
Dr. Alex, who spoke about a week-long “heart camp” that he oversees each year for 
individuals aged 8 to 17 with LQTS and other arrhythmias.  During the heart camp, 
children and adolescents engage in informational talks, including one called “Sex, Drugs, 
and Rock and Roll,” during which the topics of alcohol and substance use are discussed.  
During the interview with Dr. Alex, he laughed and said, “Well that’s why [I’m] an 
exception.  If you pick any cardiologist, not everyone may do that.”  
Another limitation of the current study includes the reliability of the measure used 
to obtain the data.  As the measure was a newly created list of interview questions that 
had not been tested previously, there was no history or evidence to support the reliability 
or validity of the questions asked.  Additionally, a common issue with self-report is that 
responses may not accurately reflect participants’ true behaviors, but rather the 
participants’ perceptions of the manner in which they treat their patients (Kazdin, 2003).  
Another potential limit is that respondents were aware that the study was being conducted 
as a psychology dissertation and, thus, this awareness may have primed participants to 
respond more favorably toward psychological screening, the need for psychological 
referrals, and the likelihood of referring a patient to an on-staff psychologist.  In the same 
vein, this awareness may have led respondents to respond more favorably toward practice 
they perceive as psychologically-sound. 
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Kazdin (2003) indicated that qualitative research is not meant to describe all 
people; rather, it is meant to expand on the meaning and understanding of experiences 
held by individuals within a specific context.  Additionally, all interviews were conducted 
by telephone, and the population of participants came from a very specific subset of 
physicians. These factors limit the generalizability of the findings.  Further, participants’ 
states of mind during the time they answered the interview questions cannot be 
determined; for example, their moods, whether they were tired, or the level of distraction 
they experienced while answering the interview questions were unclear. 
Social desirability leading to response bias may have also played a role in the 
limitations of the current study.  For example, participants may have been more inclined 
to maximize the positive aspects of their behaviors and experiences and minimize 
negative aspects.  There may have also been variability in the motivation of participants, 
which could have led to additional response bias, as some participants may have included 
more information than others in their responses.   
Lastly, another limitation associated with qualitative research is related to 
credibility, also described as the internal consistency of the results (Morrow, 2005).  
Credibility is known as the believability of the findings; there should be consistency of 
interpretations made in order to improve understanding of the phenomenon being studied 
(Kazdin, 2003).  Because of the presence of experimenter bias in qualitative research, it is 
vital to consult with other investigators to identify the level to which the data reflect the 
key concepts and overall themes identified by the researcher (Kazdin, 2003).  Thus, 
multiple coders were used in order to increase interrater reliability, or dependability of 
the findings (Morrow, 2005).  Nevertheless, it must be noted that each coder has his or 
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her own perspectives, attitudes, beliefs, and experiences, which could have led to coder 
bias within interpretation of the data. 
Future Research 
Future research is necessary in order to further explore the ambiguity associated 
with LQTS and other arrhythmias, and how this ambiguity impacts treatment of patients 
affected.  With this in mind, and based on the results of the current study, implications for 
new areas of research include determining whether a uniform protocol for addressing 
alcohol and substance use in these patients would be efficacious.  Cardiologists in this 
study seemed to express uncertainty about who holds the responsibility in regard to 
addressing alcohol and substance use issues with patients; future research could address 
whether an implemented protocol for cardiologists would be beneficial in assisting with 
distinguishing responsibility.  Moreover, a training component for early career 
cardiologists including clear guidelines may be helpful in establishing roles.  This could 
also be an area of further exploration.  
Future research could explore whether physician decision-making is impacted by 
such factors as number of years of experience.  This may be beneficial in implementing 
psychoeducation protocols for physicians, with level of experience being a factor.  
Additionally, it would be of interest of explore whether specific personality 
characteristics of physicians impact their communication styles or perspectives in regard 
to alcohol and substance use issues.  Future research could also investigate the 
perspectives of children and adolescents and their families regarding physicians’ 
approaches to alcohol and substance use.  Patients can be queried about whether they 
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receive conflicting information from their doctors, what doctors’ various 
recommendations are, and whether they follow their doctors’ advice.  
Additional research could be done incorporating the more recent national issue of 
opioid use.  It would be of value to examine how physicians’ approaches to addressing ] 
substance use may have changed since the onset of the opioid epidemic in this country, 
and how the onset of the epidemic may impact opioid use by children and adolescents 
with arrhythmias.  Moreover, future research could incorporate asking physicians 
whether they have lost patients to drug or alcohol abuse and whether such losses have 
impacted their approaches to the subject.  
A follow-up study might incorporate several changes.  First, the researcher should 
aim to conduct in-person interviews with participants in order to more clearly understand 
their experiences and to facilitate a more open interview atmosphere.  Additionally, after 
reviewing the interview transcripts, missed opportunities to engage in more in-depth 
questioning and obtain more information were identified.  In future studies, researchers 
should be prepared to ask follow-up questions in order to increase insight into and deeper 
understanding of the physician experience, as well as the patient and parent experience 
from the perspective of the physician.  
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Appendix A 
Letter Used for Cardiologist Recruitment via Standard Mail, E-Mail, and Social 
Media Announcement 
 
Dear Dr. XX, 
My name is Nicole Stewart and I am a 4th year student in the Doctor of Psychology in 
Clinical Psychology program at Philadelphia College of Osteopathic Medicine, under the 
mentorship of Stephanie H. Felgoise, Ph.D., ABPP. I am recruiting licensed 
cardiologists like yourself who treat adolescents and young adults for heart rhythm 
disorders to participate in a one-hour or less phone or in-person interview to discuss 
alcohol and substance use in their patient population. Your participation will provide 
a better understanding of the beliefs and practices of cardiologists in regard to their 
approach and treatment of adolescent and young adult patients with heart rhythm 
disorders and alcohol and substance use. Your participation and information provided 
will be held confidential and reported anonymously in aggregate with other cardiologists’ 
data. Upon completion, you will receive a $10 gift card towards Starbucks Coffee.  
 
If you are interested in participation, please reply to LQTStudies@pcom.edu with your 
contact information and best times for availability. You will be contacted within three 
days of your reply. Your consideration and assistance is greatly appreciated. If you have 
any questions about this research, you may contact my dissertation chair, Dr. Stephanie 
Felgoise, Ph.D., ABPP, stephanief@pcom.edu, or myself at (516) 652-6396 or 
nicolest@pcom.edu.  
Sincerely, 
Nicole Stewart, M.S.W., M.S. 
Philadelphia College of Osteopathic Medicine 
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Appendix B 
List of Questions Used in Cardiologist Interviews 
Demographic Questions 
 Are you board certified in cardiology?  
 Did you attend a homeopathic or osteopathic medical school? 
 Where do you practice? 
 For how many years have you been practicing medicine? 
 Is anyone in your family diagnosed with LQTS or another rhythm disorder? 
 Do you have children that are adolescent or young adult? 
 Do you have any background of mental health or substance abuse training? 
 Do you have any family members or close friends who were diagnosed with an 
alcohol or substance use disorder? 
 
Main Questions 
 
General (1) 
a. Do you consider yourself a rhythm specialist?  
b. How many years of experience do you have as a rhythm specialist? 
c. Could you estimate the percentage of patients diagnosed with rhythm 
disorders that you follow when considering the number of your total 
patients?  
d. How often do you see patients you follow for LQTS or another rhythm 
disorder? 
e. Of those who have LQTS or another rhythm disorder, how many patients 
are adolescent or young adult (13-24)?  
 
Alcohol/Substance Use 
2. Do you approach the subject of alcohol, drug, caffeine, or nicotine consumption 
when you discuss an adolescent or young adult patient’s diagnosis? 
a. If yes: 
i. What may trigger you inquiring about the topic? 
ii. What screens do you use? 
iii. Where in the patient’s “timeline” do you address it? I.e. at the 
patient’s first appointment, every appointment, every other 
appointment? How often do you inquire? 
iv. Is the patient’s parent present? 
v. Is your decision to address this topic impacted by any of the 
following? The patient’s age, whether the parent is present, the 
subtype of LQTS the patient has? 
1. At what age would you first bring this up to a patient? Why 
that age range versus another one? 
vi. What is the conversation like if the patient says they do drink 
alcohol/use nicotine/drugs/caffeine? If they say they don’t? 
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vii. What would you say to me if I was your patient and you knew I 
was using substances, caffeine, or nicotine? 
viii. Who is part of your healthcare team? 
 
b. If no: 
i. What are the reasons behind this choice?  
ii. What are the barriers? 
iii. What makes this process challenging? 
 
3. Do you screen for depression, anxiety, or other mental health diagnoses? 
a. What do you do for these patients? 
 
4. By whom else do you expect adolescents will be screened or educated about 
alcohol and substance abuse? 
a. If another provider is addressing this, do you check in with the patient 
about it? How often? 
 
5. What has influenced your approach to this topic? I.e. your clinical experience, 
literature, lawsuits? 
 
6. What would you think would be contributing to alcohol or substance use choices 
in patients who should know it is bad for them? 
 
7. What guides your decision-making in regard to addressing this topic with 
patients? 
 
8. How do you view patients who experience alcohol or substance use disorders? 
How do you view patients who use caffeine and/or nicotine? 
 
9. Is there anything else I haven’t asked you about this topic that I should have? 
 
 
